• Principal Investigator
  • Male

Prof. dr. E.S.G. Stroes MD PhD

Position: Professor
Main activities: Research, Patient care, Teaching
Specialisation: Chair department of Vascular Medicine
foto E.S.G. Stroes is one of the AMC Principal Investigators
Focus of research:

Anti-atherosclerotic strategies targeting the Vessel wall

AMC themes: Cardiovascular Diseases
Departments: Internal Medicine: Vascular Medicine
Averna M, Stroes E [Contributors: Ogura M, Postadzhiyan A, Cercek M, Calabrò P, Suppressa P]] , How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL. ATHEROSCLEROSIS SUPP 2017;26:16-24 [PubMed]
Bernelot Moens SJ, Neele AE, Kroon J, van der Valk FM, van den Bossche J, Hoeksema MA, Hoogeveen RM, Schnitzler JG, Baccara-Dinet MT, Manvelian G, de Winther MPJ, Stroes ESG, PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia. EUR HEART J 2017;38 (20):1584-1593 [PubMed]
Bernelot Moens SJ, Verweij SL, Schnitzler JG, Stiekema LCA, Bos M, Langsted A, Kuijk C, Bekkering S, Voermans C, Verberne HJ, Nordestgaard BG, Stroes ESG, Kroon J, Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans. ARTERIOSCL THROM VAS 2017;37 (5):969-975 [PubMed]
Bernelot Moens SJ, Verweij SL, van der Valk FM, van Capelleveen JC, Kroon J, Versloot M, Verberne HJ, Marquering HA, Duivenvoorden R, Vogt L, Stroes ESG, Arterial and Cellular Inflammation in Patients with CKD. J AM SOC NEPHROL 2017;28 (4):1278-1285 [PubMed]
Eeftinck Schattenkerk DW. Towards personalized antihypertensive therapy: innovate or denervate?. S.l.: s.n.; 2017. 228p. ISBN 978-94-6299-535-2 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, Reekers JA; copromotor(s): van den Born BJH, Vogt L)
Gencer B, Kronenberg F, Stroes ES, Mach F, Lipoprotein(a): the revenant. EUR HEART J 2017;38 (20):1553-1560 [PubMed]
Hovingh GK, Boekholdt SM, Stroes ES, Very low LDL-cholesterol concentrations achieved: which target is next?. LANCET 2017;390 (10106):1930-1931 [PubMed]
Kootte RS, Levin E , Salojärvi J, Smits LP, Hartstra AV, Udayappan SD, Hermes G, Bouter KE, Koopen AM, Holst JJ, Knop FK, Blaak EE, Zhao J, Smidt H, Harms AC, Hankemeijer T, Bergman JJGHM, Romijn HA, Schaap FG, Olde Damink SWM, Ackermans MT, Dallinga-Thie GM, Zoetendal E, de Vos WM, Serlie MJ, Stroes ESG, Groen AK, Nieuwdorp M, Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. CELL METAB 2017;26 (4):611-+ [PubMed]
Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Borén J, Farnier M, Ference BA, Gielen S, Graham I, Grobbee DE, Hovingh GK, Lüscher TF, Piepoli MF, Ray KK, Stroes ES, Wiklund O, Windecker S, Zamorano JL, Pinto F, Tokgözoglu L, Bax JJ, Catapano AL, 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. EUR HEART J 2017;ahead of print [PubMed]
Rosenson RS, Baker S, Banach M, Borow KM, Braun LT, Bruckert E, Brunham LR, Catapano AL, Elam MB, Mancini GBJ, Moriarty PM, Morris PB, Muntner P, Ray KK, Stroes ES, Taylor BA, Taylor VH, Watts GF, Thompson PD, Optimizing Cholesterol Treatment in Patients With Muscle Complaints. J AM COLL CARDIOL 2017;70 (10):1290-1301 [PubMed]
Rosenson RS, Gandra SR, McKendrick J, Dent R, Wieffer H, Cheng LI, Catapano AL, Oh P, Kees Hovingh G, Stroes ES, Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries. CARDIOVASC DRUG THER 2017;31 (2):187-195 [PubMed]
Schnitzler JG, Bernelot Moens SJ, Tiessens F, Bakker GJ, Dallinga-Thie GM, Groen AK, Nieuwdorp M, Stroes ESG, Kroon J, Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient- derived circulating monocytes using confocal microscopy. J LIPID RES 2017;58 (11):2210-2219 [PubMed]
Smits LP, Tiessens F, Zheng KH, Stroes ES, Nederveen AJ, Coolen BF, Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation. ATHEROSCLEROSIS 2017;263:211-218 [PubMed]
Steinhagen-Thiessen E, Stroes E, Soran H, Johnson C, Moulin P, Iotti G, Zibellini M, Ossenkoppele B, Dippel M, Averna MR, The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency. ATHEROSCLEROSIS 2017;262:146-153 [PubMed]
Stiekema LCA, Schnitzler JG, Nahrendorf M, Stroes ESG, The maturation of a 'neural-hematopoietic' inflammatory axis in cardiovascular disease. CURR OPIN LIPIDOL 2017;28 (6):507-512 [PubMed]
Stoekenbroek RM, Lokin JLC, Nielen MM, Stroes ESG, Koelemay MJW, How common are foot problems among individuals with diabetes? Diabetic foot ulcers in the Dutch population. DIABETOLOGIA 2017;60 (7):1271-1275 [PubMed]
Stroes E, Moulin P, Parhofer KG, Rebours V, Löhr JM, Averna M, Diagnostic algorithm for familial chylomicronemia syndrome. ATHEROSCLEROSIS SUPP 2017;23:1-7 [PubMed]
Toth PP, Worthy G, Gandra SR, Sattar N, Bray S, Cheng LI, Bridges I, Worth GM, Dent R, Forbes CA, Deshpande S, Ross J, Kleijnen J, Stroes ESG, Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia. J AM HEART ASSOC 2017;ahead of print [PubMed]
van Capelleveen JC, Bernelot Moens SJ, Yang X, Kastelein JJP, Wareham NJ, Zwinderman AH, Stroes ESG, Witztum JL, Hovingh GK, Khaw KT, Boekholdt SM, Tsimikas S, Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study. ARTERIOSCL THROM VAS 2017;37 (6):1206-1212 [PubMed]
van der Bel R, Çalişkan M, van Hulst RA, van Lieshout JJ, Stroes ESG, Krediet CTP, Blood Pressure Increase during Oxygen Supplementation in Chronic Kidney Disease Patients Is Mediated by Vasoconstriction Independent of Baroreflex Function. FRONT PHYSIOL 2017;8:186 [PubMed]
van der Bel R, Gurney-Champion OJ, Froeling M, Stroes ESG, Nederveen AJ, Krediet CTP, A tri-exponential model for intravoxel incoherent motion analysis of the human kidney: In silico and during pharmacological renal perfusion modulation. EUR J RADIOL 2017;91:168-174 [PubMed]
van der Valk FM, Kuijk C, Verweij SL, Stiekema LCA, Kaiser Y, Zeerleder S, Nahrendorf M, Voermans C, Stroes ESG, Increased haematopoietic activity in patients with atherosclerosis. EUR HEART J 2017;38 (6):425-+ [PubMed]
van Poelgeest EP, Dillingh MR, de Kam M, Malone KE, Kemper M, Stroes ESG, Burggraaf J, Moerland M, Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia. J PHARMACOL TOXICOL 2017;ahead of print [PubMed]
Watts GF, Stroes ESG, The shape of things to come in lipid management: a feast of reason. CURR OPIN LIPIDOL 2017;28 (6):449-451 [PubMed]
Alaarg A, Zheng KH, van der Valk FM, da Silva AE, Versloot M, van Ufford LCQ, Schulte DM, Storm G, Metselaar JM, Stroes ESG, Hamers AAJ, Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. VASC PHARMACOL 2016;82:51-59 [PubMed]
Bernelot Moens SJ. Cardiovascular disease beyond traditional risk factors: Balancing lipids and inflammation. S.l.: s.n.; 2016. 253p. ISBN 9789462334588 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, Nieuwdorp M; copromotor(s): Dallinga-Thie GM)
Bernelot Moens SJ, Stoekenbroek RM, van der Valk FM, Verweij SL, Koelemay MJW, Verberne HJ, Nieuwdorp M, Stroes ESG, Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study. BMC CARDIOVASC DISOR 2016;16 (1):237 [PubMed]
Bernelot Moens SJ, van der Valk FM, Strang AC, Kroon J, Smits LP, Kneepkens EL, Verberne HJ, van Buul JD, Nurmohamed MT, Stroes ESG, Erratum to: Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. ARTHRITIS RES THER 2016;18 (1):298 [PubMed]
Bernelot Moens SJ, van der Valk FM, Strang AC, Kroon J, Smits LP, Kneepkens EL, Verberne HJ, van Buul JD, Nurmohamed MT, Stroes ESG, Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. ARTHRITIS RES THER 2016;18 (1):115 [PubMed]
Bernelot Moens SJ, van Leuven SI, Zheng KH, Havik SR, Versloot MV, van Duivenvoorde LM, Hahne M, Stroes ESG, Baeten DL, Hamers AAJ, Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques. PLOS ONE 2016;11 (11):e0164690 [PubMed]
Cho L, Rocco M, Colquhoun D, Sullivan D, Rosenson RS, Dent R, Xue A, Scott R, Wasserman SM, Stroes E, Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study. CARDIOVASC DRUG THER 2016;30 (3):297-304 [PubMed]
Cobos Jiménez V, Wit FWNM, Joerink M, Maurer I, Harskamp AM, Schouten J, Prins M, van Leeuwen EMM, Booiman T, Deeks SG, Reiss P, Kootstra NA [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J , Kooij KW, van Zoest RA, Elsenga BC, Prins M, Martens M, Moll S, Berkel J, Totté M, Visser GR, Kovalev S, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, Reis P, Janssen FR, Heidenrijk M, Zikkenheiner W, Boumans L, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Mangas Ruiz MM, Girigorie AF, Boeser-Nunnink B, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, Nellen FJB, van der Meer JTM, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , ter Stege JA, Klein Twennaar M, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment. J INFECT DIS 2016;214 (2):216-225 [PubMed]
Demirkaya N, Wit FWNM, van den Berg TJTP, Kooij KW, Prins M, Schlingemann RO, Abramoff MD, Reiss P, Verbraak FD [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J, Kooij KW, van Zoest RA, Elsenga BC, Prins M, Martens M, Moll S, Berkel J, Totté M, Visser GR, Kovalev S, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, Kootstra NA, Harskamp-Holwerda A, Maurer I, Ruiz MMM, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Zikkenheiner W, Boumans L, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , Stege JAt, Twennaar MK, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study. INVEST OPHTH VIS SCI 2016;57 (3):1388-1397 [PubMed]
Gaudet D, Stroes ES, Méthot J, Brisson D, Tremblay K, Bernelot Moens SJ, Iotti G, Rastelletti I, Ardigo D, Corzo D, Meyer C, Andersen M, Ruszniewski P, Deakin M, Bruno MJ, Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis. HUM GENE THER 2016;27 (11):916-925 [PubMed]
Ginsberg HN, Rader DJ, Raal FJ, Guyton JR, Baccara-Dinet MT, Lorenzato C, Pordy R, Stroes E, Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher. CARDIOVASC DRUG THER 2016;30 (5):473-483 [PubMed]
Hovingh GK, Gandra SR, McKendrick J, Dent R, Wieffer H, Catapano AL, Oh P, Rosenson RS, Stroes ES, Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey. ATHEROSCLEROSIS 2016;245:111-117 [PubMed]
Jakulj L, van Dijk TH, de Boer JF, Kootte RS, Schonewille M, Paalvast Y, Boer T, Bloks VW, Boverhof R, Nieuwdorp M, Beuers UHW, Stroes ESG, Groen AK, Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion. CELL METAB 2016;24 (6):783-794 [PubMed]
Kooij KW, Wit FWNM, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, Reiss P [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J , Kooij KW, van Zoest RA, Verheij E, Elsenga BC, Prins M, Schim van der Loeff MF , Martens M, Moll S, Berkel J, Totté M, Visser GR, May L, Kovalev S, Newsum A, Dijkstra M, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, El Berkaoui A, Zikkenheiner W, Janssen FR, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Booiman T, Ruiz MMM, Girigorie AF, Boeser-Nunnink B, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Vugt M, de Bree G, van Eden J, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Bijsterveld M, Weijsenfeld A, Smalhout S, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, van der Velde N, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , Verbraak FD, Demirkaya N , Visser I, Schadé A, Nieuwkerk PT, Langebeek N, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals. J INFECT DIS 2016;214 (12):1817-1821 [PubMed]
Lobatto ME. Exploration and application of nanomedicine in atherosclerotic disease. S.l.: s.n.; 2016. 249p. ISBN 978-94-6295-424-3 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Mulder WJM, Stroes ESG; copromotor(s): Metselaar JM)
Mulders TA, Taraboanta C, Franken LC, van Heel E, Klass G, Forster BB, Arad Y, Boekholdt SM, Groenink M, Fröhlich J, Guerci AD, Stroes ESG, Pinto-Sietsma SJ, Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease. ATHEROSCLEROSIS 2016;245:155-160 [PubMed]
Nissen SE, Dent-Acosta RE, Rosenson RS, Stroes E, Sattar N, Preiss D, Mancini GBJ, Ballantyne CM, Catapano A, Gouni-Berthold I, Stein EA, Xue A, Wasserman SM, Scott R, Thompson PD [Contributors: Sullivan D, Lehman S, Kostner K, Wauchope AD, Hartleib M, Baass A, Bergeron J, Joy K, Ceska R, Adamkova V, Blaha V, Jeppesen J, Jensen HK, Bruckert E, Krempf M, Bully C, Bosiljanoff P, Gouni-Berthold I, Steinhagen-Thiessen E, Pintus P, Borghi C, Sampietro T, Vigna GB, Mannarino E, Pozzi C, Stroes E, Liem A, van Leendert R, Scott R, Kjaernli T, Langslet G, Jacovides A, Klug E, Blom D, Preiss D, Neely D, Dawson C, Miller M, Rosenson R, McCullum K, Ballantyne C, Rocco M, Shah P, Lepor N, Rosenblit P, Pokrywka G, Blazing M, Toth P, Moriarty P, Rubenfire M, Morris P, Quyyumi A, Kopecky S, Hennekens CH, Andreotti F, Baigent C, Brown WV, Davis BR, Newcomer J, Wood SK, Wiviott SD, Lowe C, Awtry E, Berger CJ, Croce K, Desai A, Gelfand E, Ho C, Leeman DE, Link MS, Norden AD, Pande A, Rost N, Ruberg F, Silverman S, Singhal A]] , Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. CLIN CARDIOL 2016;39 (3):137-144 [PubMed]
Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ESG, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, Mulder WJM, In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. JACC-CARDIOVASC IMAG 2016;9 (8):950-961 [PubMed]
Rodrigues R, Artieda M, Tejedor D, Martínez A, Konstantinova P, Petry H, Meyer C, Corzo D, Sundgreen C, Klor HU, Gouni-Berthold I, Westphal S, Steinhagen-Thiessen E, Julius U, Winkler K, Stroes E, Vogt A, Hardt P, Prophet H, Otte B, Nordestgaard BG, Deeb SS, Brunzell JD, Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency. J CLIN LIPIDOL 2016;10 (2):394-409 [PubMed]
Schouten J, Su T, Wit FW, Kootstra NA, Caan MWA, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB, Portegies P, Reiss P [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J , Kooij KW, van Zoest RA, Elsenga BC, Prins M, Stolte IG, Martens M, Moll S, Berkel J, Möller L, Visser GR, Welling C, Zaheri S, Hillebregt MMJ, Gras LAJ, Ruijs YMC, Benschop DP, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Ruiz M, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Schrijver JHN, Zikkenheiner W, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, ter Stege JA, Twennaar MK, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Schmand BA, Geurtsen GJ , Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS 2016;30 (7):1027-1038 [PubMed]
Smits LP, Coolen BF, Panno MD, Runge JH, Nijhof WH, Verheij J, Nieuwdorp M, Stoker J, Beuers UH, Nederveen AJ, Stroes ES, Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. RADIOLOGY 2016;278 (3):782-791 [PubMed]
Smits LP, van Wijk DF, Duivenvoorden R, Xu D, Yuan C, Stroes ES, Nederveen AJ, Manual versus Automated Carotid Artery Plaque Component Segmentation in High and Lower Quality 3.0 Tesla MRI Scans. PLOS ONE 2016;11 (12):e0164267 [PubMed]
Stroes E, Guyton JR, Lepor N, Civeira F, Gaudet D, Watts GF, Baccara-Dinet MT, Lecorps G, Manvelian G, Farnier M [Contributors: Kostner K, Lehman S, Descamps O, Gheyle L, Mathieu C, Bergeron J, Elliott T, Girard G, Gupta A, Hoag G, Hove J, Jeppesen J, Kjærulf JH, Klarlund K, Thomsen KK, Basart DCG, Kooy A, Liem A, Swart H, Troquay R, van Het Hof-Wiersma J, Viergever P, Visseren F, Doughty RN, Scott R, Calvo C, Díaz-Díaz JL, Fuentes F, Gil-Extremera B, Jericó C, Matas Pericas L, Mediavilla Garcia JD, Bolster DE, Koren M, El Shahawy M, Vardi G, Weinstein D, Zuzarte K, Ginsberg H, Robinson JG, Rader DJ, Cannon CP, Colhoun H, Kastelein JJP, Huo Y, Olsson A, Waters D, Larrey D, Rosenson RS, Patriarca PA, Molenberghs G, Tricoci P, Mahaffey KW, Lopes RD, Shah BR, Mehta RH, Roe MT, Eapen Z, Armaganijan L, Bertolami A, Leonardi S, Kolls BJ, Jordan JD, Ducrocq G, Puymirat E, Mathews R]] , Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study. J AM HEART ASSOC 2016;5 (9):e003421 [PubMed]
Udayappan S, Manneras-Holm L, Chaplin-Scott A, Belzer C, Herrema H, Dallinga-Thie GM, Duncan SH, Stroes ESG, Groen AK, Flint HJ, Backhed F, de Vos WM, Nieuwdorp M, Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ BIOFILMS MICROBIOMES 2016;2:16009 [PubMed]
van Capelleveen JC, van der Valk FM, Stroes ESG, Current therapies for lowering lipoprotein (a). J LIPID RES 2016;57 (9):1612-1618 [PubMed]
van der Bel R, Coolen BF, Nederveen AJ, Potters WV, Verberne HJ, Vogt L, Stroes ESG, Krediet CTP, Magnetic Resonance Imaging-Derived Renal Oxygenation and Perfusion During Continuous, Steady-State Angiotensin-II Infusion in Healthy Humans. J AM HEART ASSOC 2016;5 (3):e003185 [PubMed]
van der Hoeven NV. Reliability of blood pressure measurement and cardiovascular risk prediction. S.l.: s.n.; 2016. 179p. ISBN 978-94-6233-324-6 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): van den Born BJH, Kraaijenhagen RA)
van der Valk F. Translating lipid-driven infammation in atherosclerosis. S.l.: s.n.; 2016. 273p. ISBN 978-94-6299-418-8 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, Nieuwdorp M; copromotor(s): Nederveen AJ)
van der Valk FM, Bekkering S, Kroon J, Yeang C, van den Bossche J, van Buul JD, Ravandi A, Nederveen AJ, Verberne HJ, Scipione C, Nieuwdorp M, Joosten LAB, Netea MG, Koschinsky ML, Witztum JL, Tsimikas S, Riksen NP, Stroes ESG, Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. CIRCULATION 2016;134 (8):611-624 [PubMed]
van der Valk FM, Bernelot Moens SJ, Verweij SL, Strang AC, Nederveen AJ, Verberne HJ, Nurmohamed MT, Baeten DL, Stroes ESG, Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy. ANN RHEUM DIS 2016;75 (10):1848-1851 [PubMed]
van der Valk FM, Schulte DM, Meiler S, Tang J, Zheng KH, van den Bossche J, Seijkens T, Laudes M, de Winther M, Lutgens E, Alaarg A, Metselaar JM, Dallinga-Thie GM, Mulder WJM, Stroes ESG, Hamers AAJ, Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis. NANOMED-NANOTECHNOL 2016;12 (6):1463-1470 [PubMed]
van der Valk FM, Verweij SL, Zwinderman KAH, Strang AC, Kaiser Y, Marquering HA, Nederveen AJ, Stroes ESG, Verberne HJ, Rudd JHF, Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies. JACC-CARDIOVASC IMAG 2016;9 (10):1198-1207 [PubMed]
van Wijk DF, Boekholdt SM, Arsenault BJ, Ahmadi-Abhari S, Wareham NJ, Stroes ESG, Khaw KT, C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study. J AM HEART ASSOC 2016;ahead of print [PubMed]
Viney NJ, van Capelleveen JC, Geary RS, Xia S, Tami JA, Yu RZ, Marcovina SM, Hughes SG, Graham MJ, Crooke RM, Crooke ST, Witztum JL, Stroes ES, Tsimikas S, Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. LANCET 2016;388 (10057):2239-2253 [PubMed]
Zheng KH, Stroes ESG, HDL infusion for the management of atherosclerosis: current developments and new directions. CURR OPIN LIPIDOL 2016;27 (6):592-596 [PubMed]
Zheng KH, van der Valk FM, Smits LP, Sandberg M, Dasseux JL, Baron R, Barbaras R, Keyserling C, Coolen BF, Nederveen AJ, Verberne HJ, Nell TE, Vugts DJ, Duivenvoorden R, Fayad ZA, Mulder WJM, van Dongen GAMS, Stroes ESG, HDL mimetic CER-001 targets atherosclerotic plaques in patients. ATHEROSCLEROSIS 2016;251:381-388 [PubMed]
Bochem AE, van der Valk FM, Tolani S, Stroes ES, Westerterp M, Tall AR, Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins. ARTERIOSCL THROM VAS 2015;35 (7):1663-1669 [PubMed]
Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Descamps OS, Steinhagen-Thiessen E, Tybjaerg-Hansen A, Watts GF, Averna M, Boileau C, Borén J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AFH, Stroes E, Taskinen MR, Wiegman A, Wiklund O, Chapman MJ [Contributors: Cuchel M, Bruckert E, Chapman MJ, Descamps OS, Ginsberg HN, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Raal FJ, Santos RD, Steinhagen-Thiessen E, Tybjaerg-Hansen A, Watts GF, Averna M, Boileau C, Bore'n J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AFH, Stroes E, Taskinen MR, Wiegman A, Wiklund O]] , Homozigot ailevi hiperkolesterolemi: klinisyenlerin taniyi ve klinik yönetimi geliştirmelerine yönelik yeni anlayişlar ve rehberlik. Avrupa Ateroskleroz Derneği'nin Ailevi Hiperkolesterolemi Üzerine Uzlaşi Paneli yazili görüşü. TURK KARDIYOL DERN ARS 2015;43 (Suppl. 1):1-14 [PubMed]
Hovingh GK, Smits LP, Stefanutti C, Soran H, Kwok S, de Graaf J, Gaudet D, Keyserling CH, Klepp H, Frick J, Paolini JF, Dasseux JL, Kastelein JJP, Stroes ES, The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study. AM HEART J 2015;169 (5):736-742.e1 [PubMed]
Kootte RS, Smits LP, van der Valk FM, Dasseux JL, Keyserling CH, Barbaras R, Paolini JF, Santos RD, van Dijk TH, Dallinga-van Thie GM, Nederveen AJ, Mulder WJM, Hovingh GK, Kastelein JJP, Groen AK, Stroes ES, Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA. J LIPID RES 2015;56 (3):703-712 [PubMed]
Lobatto ME, Calcagno C, Millon A, Senders ML, Fay F, Robson PM, Ramachandran S, Binderup T, Paridaans MPM, Sensarn S, Rogalla S, Gordon RE, Cardoso L, Storm G, Metselaar JM, Contag CH, Stroes ESG, Fayad ZA, Mulder WJM, Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. ACS NANO 2015;9 (2):1837-1847 [PubMed]
Lobatto ME, Calcagno C, Otten MJ, Millon A, Ramachandran S, Paridaans MPM, van der Valk FM, Storm G, Stroes ESG, Fayad ZA, Mulder WJM, Metselaar JM, Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. NANOMED-NANOTECHNOL 2015;11 (5):1133-1140 [PubMed]
Mooij HL. Functional consequences of inborn and acquired errors in endothelial glycocalyx heparan sulfates. S.l.: s.n.; 2015. 212p. ISBN 978-94-6182-547-6 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, Vink H; copromotor(s): Nieuwdorp M, Dallinga-Thie GM)
Mooij HL, Bernelot Moens SJ, Gordts PLSM, Stanford KI, Foley EM, van den Boogert MAW, Witjes JJ, Hassing HC, Tanck MW, van de Sande MAJ, Levels JH, Kastelein JJP, Stroes ESG, Dallinga-Thie GM, Esko JD, Nieuwdorp M, Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans. J LIPID RES 2015;56 (3):665-673 [PubMed]
Nahrendorf M, Frantz S, Swirski FK, Mulder WJM, Randolph G, Ertl G, Ntziachristos V, Piek JJ, Stroes ES, Schwaiger M, Mann DL, Fayad ZA, Imaging systemic inflammatory networks in ischemic heart disease. J AM COLL CARDIOL 2015;65 (15):1583-1591 [PubMed]
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJP [Contributors: Caccavo A, Codutti O, Gelersztein E, Vico M, Zaidman C, Majul C, Balthazar Y, Capiau L, Vrolix M, Vermeersch P, Gotchev D, Todorov G, Tumbev H, Tzekova M, Gronkova N, Dimov B, Nikolaeva A, Devedzhiev T, Mincheva V, D'Ignazio G, Dzongowski P, Elliott T, Hart R, Hoag G, Martinho V, O'Mahony M, Tellier G, Bergeron J, Pandey S, Heaton K, Constance C, Phaneuf DC, Shu D, Narvaez NC, Cañon CO, Cardenas SP, Loayza MS, de Salazar DM, Lopez RB, Gomez JI, Mendoza JA, Cure CC, Ceska R, Zidkova E, Jansky P, Egstrup K, Klausen IBC, Lomholdt J, Gislason G, Torp-Pedersen C, Poulsen S, Kuusela M, Kekki S, Nieminen S, Tuomilehto J, Boye A, Bruckert E, Cadinot D, Farnier M, Lejay D, Luc G, Revol T, Schaupp T, Krempf M, Bonnet J, Paillard F, Moulin P, Junggeburth J, Isermann B, Zühlke M, Züchner D, Theis E, Stößel J, König HJ, Rinke A, Piechatzek R, Contzen C, Lappo M, Himpel-Boenninghoff AA, Meissner G, Maus O, Degtyareva E, Schulze ED, Horacek T, Marten I, Becher P, Matoltsy A, Nyirati G, Paragh G, Zilahi Z, Nagy K, Kanakaridisz N, Beke E, Biro J, Schnabel R, Elias M, Gavish D, Francis A, Nseir W, Zimlichman R, Averna M, Pozzi C, Lembo G, Bucci M, Mezzetti A, Rubba P, de Pellegrin AM, Salvioni A, de Cesare N, Briones IR, Campos PF, Rosas EL, Espinosa EV, Salazar MA, Ruiz AB, Furusho LC, Olvera I, Stroes E, van den Berg R, Basart D, Köse V, Kentgens S, Peeters M, Hoogendijk J, Voors-Pette C, Agous I, van Kempen W, Lingan GR, Kooy A, Troquay R, Herrman J, Hoivik H, Langslet G, Norheim P, Risberg K, Høivik HO, Elle S, Derezinski T, Miekus P, Ogorek M, Szymkowiak K, Cesar M, Gawron A, Dabrowska M, Blach E, Konieczny M, Sidor M, Matias F, da Silva PM, Carvalho D, Mendonca I, Andor M, Andrei L, Podoleanu C, Pop C, Chizhov P, Chumakova G, Goloschekin B, Libov I, Paltsman Z, Strutinskiy A, Koziolova N, Breedt J, Ebrahim I, Ellis G, Fulat M, van Rensburg DJ, Raal F, van Dyk C, Vally T, van der Walt E, Kotzé H, Landman C, Tayob M, Caixas A, García LR, Fernandez-Cruz A, Gil-Extremera B, Grijalvo OM, Plana N, Fuentes F, Valdivielso P, Fraile B, Borgencrantz B, Larnefeldt H, Tengmark BO, Eriksson M, Olsson-Önerud Å, Amalyan W, Dyadyk O, Koval O, Kushnir M, Svintsitskiy A, Kovalyov O, Bondarchuk O, Tashchuk V, Barna O, Prokhorov O, Karpenko O, Stanciu D, Pawa R, Balaji H, Doig F, Harvey P, Ranganath L, Massalski W, Hassanin H, Timmis H, Pavel-Knox I, Abdulhakim E, Oyesile B, Horvathova V, Donnachie H, Kondagunta V, Shaw H, Thomas H, Kadr H, Gunstone A, Lip G, Ellery A, Kerrane J, Sarker A, Wong Yk, Soran H, Maw K, Andersen J, Blair-Britt L, Huffman C, Kivitz A, Marple R, Patron A, Schear M, Allegar N, Awasty V, Casanova R, Chaykin L, Cohen L, Collins H, Collins G, Elkin G, Reyes H, Feld L, Fuller G, Glover R, Greenwald J, Herrod J, Kaye W, Kimmel M, Kolettis E, Lakin G, Lorch D, Palatnik M, Patel R, Reichman A, Rohlf J, Shockey G, Shore K, Radin D, Alvarado O, Bellingar B, Egelhof R, McKnight T, Plevin S, Pritchard J, Reddy R, Velazquez F, Bolster E, Broker R, Butuk D, Cheung D, Cohen K, Golden G, Murray A, Naccarato T, Uusinarkaus K, Pudi K, Graff A, Blumberg V, Dunn F, Toth P, Anspach R, Chuang R, Meli J, Nevins B, Wayne J, Schmidt L, Levinsky D, Rubino J, Shealy N, Torres D, West J, Jain R, Vardi G, Singh N, Thew S, Lo E, Heitner J, Gerber J, Malik A, Weinstein D, Prashad R, Koren M, Ghitis A, David W, Reis G, Kinzfogl G, Haught H, Kantaros L, O'dea D, Weiss D, Kassas S, Hunter J, Mollod M, Khan N, Henderson D, Gatien L, Schramm R, Madder R, El Shahawy M, Voyce S, Nadar V, Stich M, Kumar M, Black R, Treasure C, Lebeis M, McCullough P, Lepor N, Moriarty P, Waxler A, Talreja D, Gen M, Dohad S, East C, Conrad G, Asbill B, Roberts J, Robinson J, Zarich S, Davis B, Krolick M, Sherman H, Thompson P]] , Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events. NEW ENGL J MED 2015;372 (16):1489-1499 [PubMed]
Schwarz JCV, Duivenvoorden R, Nederveen AJ, Stroes ESG, VanBavel E, Endothelial shear stress estimation in the human carotid artery based on Womersley versus Poiseuille flow. INT J CARDIOVAS IMAG 2015;31 (3):585-593 [PubMed]
Siemelink M, den Ruijter H, van der Valk F, de Vries JP, de Borst GJ, Moll F, Stroes E, Pasterkamp G, Systemic Glucocorticoids Are Associated With Mortality After Carotid Endarterectomy. J CARDIOVASC PHARM 2015;66 (4):392-398 [PubMed]
Stoekenbroek RM, Rensing KL, Bernelot Moens SJ, Nieuwdorp M, DeVries JH, Zwinderman AH, Stroes ES, Currie CJ, Hutten BA, High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events. ATHEROSCLEROSIS 2015;240 (2):318-323 [PubMed]
Stoekenbroek RM, Stroes ES, Hovingh GK, ApoA-I mimetics. HANDB EXP PHARMACOL 2015;224:631-648 [PubMed]
Strang AC. Imaging of arterial wall inflammation. S.l.: s.n.; 2015. 207p. ISBN 978-94-6182-544-5 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, Tak PP; copromotor(s): Rotmans JI, Bisoendial RJ)
Strang AC, Knetsch MLW, Koole LH, de Winter RJ, van der Wal AC, de Vries CJM, Tak PP, Bisoendial RJ, Stroes ESG, Rotmans JI, Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model. PLOS ONE 2015;10 (3):e0122836 [PubMed]
Strang AC, van Wijk DF, Mutsaerts HJMM, Stroes ESG, Nederveen AJ, Rotmans JI, Rabelink TJ, Box FMA, Guideline treatment results in regression of atherosclerosis in type 2 diabetes mellitus. DIABETES VASC DIS RE 2015;12 (2):126-132 [PubMed]
Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoğlu L, Nordestgaard BG, Bruckert E, de Backer G, Krauss RM, Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, März W, Newman CB, Wiklund O, Jacobson TA, Catapano AL, Chapman MJ, Ginsberg HN [Contributors: Stroes E, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoğlu L, Nordestgaard BG, Bruckert E, Krauss RM, Laufs U, Santos RD, März W, Newman CB, Chapman MJ, Ginsberg HN, de Backer G, Catapano AL, Hegele RA, Hovingh GK, Jacobson TA, Leiter L, Mach F, Wiklund O]] , Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. EUR HEART J 2015;36 (17):1012-1022 [PubMed]
Stroes ES, van der Valk FM, A sense of excitement for a specific Lp(a)-lowering therapy. LANCET 2015;386 (10002):1427-1429 [PubMed]
Tang J, Lobatto ME, Hassing L, van der Staay S, van Rijs SM, Calcagno C, Braza MS, Baxter S, Fay F, Sanchez-Gaytan BL, Duivenvoorden R, Sager H, Astudillo YM, Leong W, Ramachandran S, Storm G, Pérez-Medina C, Reiner T, Cormode DP, Strijkers GJ, Stroes ESG, Swirski FK, Nahrendorf M, Fisher EA, Fayad ZA, Mulder WJM, Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. SCI ADV 2015;1 (3):e1400223 [PubMed]
van der Hoeven NV, Niessen MAJ, Stroes ESG, Burdorf L, Kraaijenhagen RA, van den Born BJH, A six question screen to facilitate primary cardiovascular disease prevention. BMC CARDIOVASC DISOR 2015;15 (1):140 [PubMed]
van der Valk FM, Sluimer JC, Vöö SA, Verberne HJ, Nederveen AJ, Windhorst AD, Stroes ESG, Lambin P, Daemen MJAP, In Vivo Imaging of Hypoxia in Atherosclerotic Plaques in Humans. JACC-CARDIOVASC IMAG 2015;8 (11):1340-1341 [PubMed]
van der Valk FM, van Wijk DF, Lobatto ME, Verberne HJ, Storm G, Willems MCM, Legemate DA, Nederveen AJ, Calcagno C, Mani V, Ramachandran S, Paridaans MPM, Otten MJ, Dallinga-Thie GM, Fayad ZA, Nieuwdorp M, Schulte DM, Metselaar JM, Mulder WJM, Stroes ES, Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. NANOMED-NANOTECHNOL 2015;11 (5):1039-1046 [PubMed]
van Wijk DF, Strang AC, Duivenvoorden R, Enklaar DJF, Zwinderman AH, van der Geest RJ, Kastelein JJP, de Groot E, Stroes ESG, Nederveen AJ, Increasing the Spatial Resolution of 3T Carotid MRI Has No Beneficial Effect for Plaque Component Measurement Reproducibility. PLOS ONE 2015;10 (7):e0130878 [PubMed]
Verweij SL, van der Valk FM, Stroes ESG, Novel directions in inflammation as a therapeutic target in atherosclerosis. CURR OPIN LIPIDOL 2015;26 (6):580-585 [PubMed]
Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Defesche JC, Descamps OS, Hegele RA, Hovingh GK, Humphries SE, Kovanen PT, Kuivenhoven JA, Masana L, Nordestgaard BG, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AFH, Steinhagen-Thiessen E, Stroes ES, Taskinen MR, Tybjærg-Hansen A, Wiklund O [Contributors: Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Chapman MJ, Cuchel M, Defesche JC, Descamps OS, Gidding SS, Ginsberg HN, Hegele RA, Hovingh GK, Humphries SE, Kovanen PT, Kuivenhoven JA, Masana L, Nordestgaard BG, Ose L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AFH, Steinhagen-Thiessen E, Stroes ES, Taskinen MR, Tybjærg-Hansen A, Watts GF, Wiegman A, Wiklund O]] , Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. EUR HEART J 2015;36 (36):2425-2437 [PubMed]
Bernelot Moens SJ, Mooij HL, Hassing HC, Kruit JK, Witjes JJ, van de Sande MAJ, Nederveen AJ, Xu D, Dallinga-Thie GM, Esko JD, Stroes ESG, Nieuwdorp M, Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume. PLOS ONE 2014;9 (12):e115662 [PubMed]
Bernelot Moens SJ, van Capelleveen JC, Stroes ESG, Inhibition of ApoCIII: the next PCSK9?. CURR OPIN LIPIDOL 2014;25 (6):418-422 [PubMed]
Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, Dallinga GM , Motazacker MM, Hovingh GK, Kuivenhoven JA, Stroes ESG, Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT. PLOS ONE 2014;9 (5):e90967 [PubMed]
Bochem AE, van Capelleveen JC, Dallinga-Thie GM, Schimmel AWM, Motazacker MM, Tietjen I, Singaraja RR, Hayden MR, Kastelein JJP, Stroes ESG, Hovingh GK, Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families. CLIN GENET 2014;85 (5):433-440 [PubMed]
Cho L, Rocco M, Colquhoun D, Sullivan D, Rosenson RS, Dent R, Xue A, Scott R, Wasserman SM, Stroes E, Design and Rationale of the GAUSS-2 Study Trial: A Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy. CLIN CARDIOL 2014;37 (3):131-139 [PubMed]
Colin S, Fanchon M, Belloy L, Bochem AE, Copin C, Derudas B, Stroes ESG, Hovingh GK, Kuivenhoven JA, Dallinga-Thie GM, Staels B, Chinetti-Gbaguidi G, HDL does not influence the polarization of human monocytes toward an alternative phenotype. INT J CARDIOL 2014;172 (1):179-184 [PubMed]
Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Descamps OS, Steinhagen-Thiessen E, Tybjærg-Hansen A, Watts GF, Averna M, Boileau C, Borén J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AFH, Stroes E, Taskinen MR, Wiegman A, Wiklund O, Chapman MJ [Contributors: Chapman MJ, Ginsberg HN, Averna M, Boileau C, Borén J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AFH, Stroes E, Taskinen MR, Wiegman A, Wiklund O]] , Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. EUR HEART J 2014;35 (32):2146-2157 [PubMed]
Dillingh MR, van Poelgeest EP, Malone KE, Kemper EM, Stroes ESG, Moerland M, Burggraaf J, Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers. J INFLAMM-LOND 2014;11:28
Duivenvoorden R, Stroes ESG, Hovingh GK, The value of screening for carotid plaque in patients referred for echocardiography. CAN J CARDIOL 2014;30 (10):1148-1149 [PubMed]
Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, Otten MJ, Zaidi N, Lobatto ME, van Rijs SM, Priem B, Kuan EL, Martel C, Hewing B, Sager H, Nahrendorf M, Randolph GJ, Stroes ESG, Fuster V, Fisher EA, Fayad ZA, Mulder WJM, A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. NAT COMMUN 2014;5:3065 [PubMed]
Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, Otten MJ, Zaidi N, Lobatto ME, van Rijs SM, Priem B, Kuan EL, Martel C, Hewing B, Sager H, Nahrendorf M, Randolph GJ, Stroes ESG, Fuster V, Fisher EA, Fayad ZA, Mulder WJM, Erratum: A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. NAT COMMUN 2014;5:3531 [PubMed]
Frenkel WJ. Susceptibility to hyponatremia in the elderly: causes and consequences. S.l.: s.n.; 2014. 147p. ISBN 9789461086884 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, de Rooij SEJA; copromotor(s): van den Born BJH, Vogt L)
Hashemi N, Odze RD, McGowan MP, Santos RD, Stroes ESG, Cohen DE, Liver histology during Mipomersen therapy for severe hypercholesterolemia. J CLIN LIPIDOL 2014;8 (6):606-611 [PubMed]
Hassing HC, Surendran RP, Derudas B, Verrijken A, Francque SM, Mooij HL, Bernelot Moens SJ, Hart LMt, Nijpels G, Dekker JM, Williams KJ, Stroes ESG, van Gaal LF, Staels B, Nieuwdorp M, Dallinga-Thie GM, SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus. OBESITY 2014;22 (5):1309-1316 [PubMed]
Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Borén J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AFH, Stroes E, Taskinen MR, Tybjærg-Hansen A, Watts GF, Wiklund O, The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. LANCET DIABETES ENDO 2014;2 (8):655-666 [PubMed]
Kim Y, Lobatto ME, Kawahara T, Lee Chung B, Mieszawska AJ, Sanchez-Gaytan BL, Fay F, Senders ML, Calcagno C, Becraft J, Tun Saung M, Gordon RE, Stroes ESG, Ma M, Farokhzad OC, Fayad ZA, Mulder WJM, Langer R, Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. P NATL ACAD SCI USA 2014;111 (3):1078-1083 [PubMed]
Kuroda M, Holleboom AG, Stroes ESG, Asada S, Aoyagi Y, Kamata K, Yamashita S, Ishibashi S, Saito Y, Bujo H, Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency. ARTERIOSCL THROM VAS 2014;34 (8):1756-1762 [PubMed]
Luijendijk P, Bouma BJ, Vriend JWJ, Groenink M, Vliegen HW, de Groot E, Pieper PG, van Dijk APJ, Sieswerda GT, Konings TC, Stroes ES, Zwinderman AH, Mulder BJM, Beneficial effect of high dose statins on the vascular wall in patients with repaired aortic coarctation?. INT J CARDIOL 2014;176 (1):40-47 [PubMed]
Mooij HL, Cabrales P, Bernelot Moens SJ, Xu D, Udayappan SD, Tsai AG, van der Sande MAJ, de Groot E, Intaglietta M, Kastelein JJP, Dallinga-Thie GM, Esko JD, Stroes ES, Nieuwdorp M, Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function. J AM HEART ASSOC 2014;3 (6):e001274 [PubMed]
Niesor EJ, Kallend D, Bentley D, Kastelein JJP, Kees Hovingh G, Stroes ESG, Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutations. LIPIDS 2014;49 (12):1245-1249 [PubMed]
Noveck R, Stroes ESG, Flaim JD, Baker BF, Hughes S, Graham MJ, Crooke RM, Ridker PM, Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers. J AM HEART ASSOC 2014;3 (4):e001084 [PubMed]
Rensing KL, de Jager SCA, Stroes ES, Vos M, Twickler MTB, Dallinga-Thie GM, de Vries CJM, Kuiper J, Bot I, von der Thüsen JH, Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. CARDIOVASC RES 2014;101 (2):277-287 [PubMed]
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P [Contributors: Wit FWNM, van der Valk M, Schouten J, Kooij KW, van Zoest RA, Elsenga BC, Prins M, Stolte IG, Martens M, Moll S, Berkel J, Möller L, Visser GR, Welling C, Zaheri S, Hillebregt MMJ, Gras LAJ, Ruijs YMC, Benschop DP, Reiss P, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Ruiz MMM, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Schrijver JHN, Zikkenheiner W, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, Henderiks A, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , Stege JAt, Twennaar MK, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. CLIN INFECT DIS 2014;59 (12):1787-1797 [PubMed]
Smits LP, Kootte RS, Stroes ES, Reversal of atherosclerosis with apolipoprotein A1: back to basics. ATHEROSCLEROSIS 2014;232 (1):217-219 [PubMed]
Strang AC, Knetsch MLW, Idu MM, Bisoendial RJ, Kramer G, Speijer D, Koole LH, Stroes ESG, Rotmans JI, Superior in vivo compatibility of hydrophilic polymer coated prosthetic vascular grafts. J VASC ACCESS 2014;15 (2):95-101 [PubMed]
Stroes E, Colquhoun D, Sullivan D, Civeira F, Rosenson RS, Watts GF, Bruckert E, Cho L, Dent R, Knusel B, Xue A, Scott R, Wasserman SM, Rocco M, Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. J AM COLL CARDIOL 2014;63 (23):2541-2548 [PubMed]
van der Valk F, Hassing C, Visser M, Thakkar P, Mohanan A, Pathak K, Dutt C, Chauthaiwale V, Ackermans M, Nederveen A, Serlie M, Nieuwdorp M, Stroes E, The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial. PLOS ONE 2014;9 (2):e86890 [PubMed]
van der Valk FM, Kroon J, Potters WV, Thurlings RM, Bennink RJ, Verberne HJ, Nederveen AJ, Nieuwdorp M, Mulder WJM, Fayad ZA, van Buul JD, Stroes ESG, In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans. J AM COLL CARDIOL 2014;64 (10):1019-1029 [PubMed]
van Wijk DF. Inflammation in atherosclerosis. Imaging, biomarkers and novel therapeutic opportunities. s.l.: s.n.; 2014. 298p. ISBN 9789462591790 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): Nederveen AJ, Boekholdt SM)
van Wijk DF, Sjouke B, Figueroa A, Emami H, van der Valk FM, MacNabb MH, Hemphill LC, Schulte DM, Koopman MG, Lobatto ME, Verberne HJ, Fayad ZA, Kastelein JJP, Mulder WJM, Hovingh GK, Tawakol A, Stroes ESG, Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia. J AM COLL CARDIOL 2014;64 (14):1418-1426 [PubMed]
van Wijk DF, Strang AC, Duivenvoorden R, Enklaar DJF, van der Geest RJ, Kastelein JJP, de Groot E, Stroes ESG, Nederveen AJ, Increasing spatial resolution of 3T MRI scanning improves reproducibility of carotid arterial wall dimension measurements. MAGN RESON MATER PHY 2014;27 (3):219-226 [PubMed]
Vinjé S, Stroes E, Nieuwdorp M, Hazen SL, The gut microbiome as novel cardio-metabolic target: the time has come!. EUR HEART J 2014;35 (14):883-887 [PubMed]
Vrieze A , Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, van Nood E, Holleman F, Knaapen M, Romijn JA, Soeters MR, Blaak EE, Dallinga-Thie GM, Reijnders D, Ackermans MT, Serlie MJ, Knop FK, Holst JJ, van der Ley C, Kema IP, Zoetendal EG, de Vos WM, Hoekstra JBL, Stroes ES, Groen AK, Nieuwdorp M, Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J HEPATOL 2014;60 (4):824-831 [PubMed]
Bernelot Moens SJ, Hassing CH, Nieuwdorp M, Stroes ESG, Dallinga-Thie GM, Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies. CLIN LIPIDOL 2013;8 (3):321-328
Besseling J, Hovingh GK, Stroes ESG, Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises. NETH J MED 2013;71 (3):118-122 [PubMed]
Bochem AE. HDL cholesterol: atherosclerosis and beyond. s.l.: s.n.; 2013. 293p. ISBN 9789461823700 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): Hovingh GK, Kuivenhoven JA)
Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, Dallinga-Thie GM, Motazacker MM, Hovingh GK, Kuivenhoven JA, Stroes ESG, High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C. J LIPID RES 2013;54 (6):1698-1704 [PubMed]
Bochem AE, Kuivenhoven JA, Stroes ESG, The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease. CURR PHARM DESIGN 2013;19 (17):3143-3149 [PubMed]
Bochem AE, van Wijk DF, Holleboom AG, Duivenvoorden R, Motazacker MM, Dallinga-Thie GM, de Groot E, Kastelein JJP, Nederveen AJ, Hovingh GK, Stroes ESG, ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden. EUR HEART J 2013;34 (4):286-291 [PubMed]
Cormode DP, Fisher EA, Stroes ESG, Mulder WJM, Fayad ZA, High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein. P NATL ACAD SCI USA 2013;110 (38):E3548 [PubMed]
Duivenvoorden R. Innovative imaging techniques for improved characterization of atherosclerosis and the assessment of novel therapies. s.l.: s.n.; 2013. 301p. ISBN 97890902777226 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Stroes ESG; copromotor(s): Nederveen AJ, de Groot E, Mulder WJM)
Duivenvoorden R, van Wijk D, Klimas M, Kastelein JJP, Stroes ESG, Nederveen AJ, Detection of liquid phase cholesteryl ester in carotid atherosclerosis by 1H-MR spectroscopy in humans. JACC-CARDIOVASC IMAG 2013;6 (12):1277-1284 [PubMed]
Eeftinck Schattenkerk DW, van den Bogaard B, Cammenga M, Westerhof BE, Stroes ESG, van den Born BJH, Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure. J HYPERTENS 2013;31 (12):2447-2454 [PubMed]
Hassing HC. Glycobiology in cardiometabolic homeostasis. s.l.: s.n.; 2013. 227p. ISBN 978946191735578 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): Nieuwdorp M, Dallinga-Thie GM)
Holleboom AG, Jakulj L, Franssen R, Decaris J, Vergeer M, Koetsveld J, Luchoomun J, Glass A, Hellerstein MK, Kastelein JJP, Hovingh GK, Kuivenhoven JA, Groen AK, Turner SM, Stroes ESG, In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1. J LIPID RES 2013;54 (7):1964-1971 [PubMed]
Jakulj L. Intestinal cholesterol transport: measuring cholesterol absorption and its reverse. s.l.: s.n.; 2013. 176p. ISBN 9789082043709 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Groen AK, Stroes ESG; copromotor(s): Vissers MN)
Jakulj L, Besseling J, Stroes ESG, Groen AK, Intestinal cholesterol secretion: future clinical implications. NETH J MED 2013;71 (9):459-465 [PubMed]
Jakulj L, Mohammed H, van Dijk TH, Boer T, Turner S, Groen AK, Vissers MN, Stroes ESG, Plasma plant sterols serve as poor markers of cholesterol absorption in man. J LIPID RES 2013;54 (4):1144-1150 [PubMed]
Knaapen M, Kootte RS, Zoetendal EG, de Vos WM, Dallinga-Thie GM, Levi M, Stroes ES, Nieuwdorp M, Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?. CLIN MICROBIOL INFEC 2013;19 (4):331-337 [PubMed]
Mulders TA. Premature atherosclerosis: sounds familial. s.l.: s.n.; 2013. 209p. ISBN 9789461936662 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): Pinto-Sietsma SJ, Vink H)
Mulders TA, Nieuwdorp M, Stroes ES, Vink H, Pinto-Sietsma SJ, Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease. INT J CARDIOL 2013;168 (5):5026-5028 [PubMed]
Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AFH, Stroes E, Taskinen MR, Tybjærg-Hansen A, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. EUR HEART J 2013;34 (45):3478-390a [PubMed]
Scicluna BP, van 't Veer C, Nieuwdorp M, Felsmann K, Wlotzka B, Stroes ESG, van der Poll T, Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome. PLOS ONE 2013;8 (11):e79051 [PubMed]
Sjouke B, Balak DMW, Beuers U, Ratziu V, Stroes ESG, Is mipomersen ready for clinical implementation? A transatlantic dilemma. CURR OPIN LIPIDOL 2013;24 (4):301-306 [PubMed]
Smit KF, Oei GTML, Brevoord D, Stroes ES, Nieuwland R, Schlack WS, Hollmann MW, Weber NC, Preckel B, Helium induces preconditioning in human endothelium in vivo. ANESTHESIOLOGY 2013;118 (1):95-104 [PubMed]
Sondermeijer BM, Battjes S, van Dijk TH, Ackermans MT, Serlie MJ, Nieuwdorp M, Groen AK, Dallinga-Thie GM, Stroes ESG, Lactate increases hepatic secretion of VLDL-triglycerides in humans. ATHEROSCLEROSIS 2013;228 (2):443-450 [PubMed]
Spijkers LJA. Sphingolipids in essential hypertension and endothelial dysfunction. s.l.: s.n.; 2013. 224p. ISBN 9789461084019 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, de Mey JGR; copromotor(s): Peters SLM, Alewijnse AE)
Strang AC, Bisoendial RJ, Kootte RS, Schulte DM, Dallinga-Thie GM, Levels JHM, Kok M, Vos K, Tas SW, Tietge UJF, Müller N, Laudes M, Gerlag DM, Stroes ESG, Tak PP, Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. ATHEROSCLEROSIS 2013;229 (1):174-181 [PubMed]
van Wijk DF, Boekholdt SM, Wareham NJ, Ahmadi-Abhari S, Kastelein JJP, Stroes ESG, Khaw KT, C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study. ARTERIOSCL THROM VAS 2013;33 (12):2888-2894 [PubMed]
Bisoendial RJ, Tanck MW, Golledge J, Broekhuizen LN, Legemate DA, Stroes ESG, Norman PE, The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysms. ATHEROSCLEROSIS 2012;220 (2):425-428 [PubMed]
Boekholdt SM, Stroes ESG, The interleukin-6 pathway and atherosclerosis. LANCET 2012;379 (9822):1176-1178 [PubMed]
Franssen R, Schimmel AWM, van Leuven SI, Wolfkamp SCS, Stroes ESG, Dallinga-Thie GM, In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL. CHOLESTEROL 2012;2012:610741 [PubMed]
Hassing HC, Mooij H, Guo S, Monia BP, Chen K, Kulik W, Dallinga-Thie GM, Nieuwdorp M, Stroes ESG, Williams KJ, Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia. HEPATOLOGY 2012;55 (6):1746-1753 [PubMed]
Hassing HC, Surendran RP, Mooij HL, Stroes ES, Nieuwdorp M, Dallinga-Thie GM, Pathophysiology of hypertriglyceridemia. BBA-MOL CELL BIOL L 2012;1821 (5):826-832 [PubMed]
Holleboom AG, Daniil G, Fu X, Zhang R, Hovingh GK, Schimmel AW, Kastelein JJP, Stroes ESG, Witztum JL, Hutten BA, Tsimikas S, Hazen SL, Chroni A, Kuivenhoven JA, Lipid Oxidation in Carriers of Lecithin: Cholesterol Acyltransferase Gene Mutations. ARTERIOSCL THROM VAS 2012;32 (12):3066-+ [PubMed]
Huijgen R, Stork ADM, Defesche JC, Peter J, Alonso R, Cuevas A, Kastelein JJP, Duran M, Stroes ESG, Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis. CLIN GENET 2012;81 (1):24-28 [PubMed]
Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, Groen AK, Hoekstra JBL, Stroes ES, Nieuwdorp M, The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. DIABETES OBES METAB 2012;14 (2):112-120 [PubMed]
Lobatto ME, Calcagno C, Metselaar JM, Storm G, Stroes ESG, Fayad ZA, Mulder WJM, IMAGING THE EFFICACY OF ANTI-INFLAMMATORY LIPOSOMES IN A RABBIT MODEL OF ATHEROSCLEROSIS BY NON-INVASIVE IMAGING. METHOD ENZYMOL 2012;508:211-228 [PubMed]
Mulders TA, Sivapalaratnam S, Stroes ESG, Kastelein JJP, Guerci AD, Pinto-Sietsma SJ, Asymptomatic Individuals With a Positive Family History for Premature Coronary Artery Disease and Elevated Coronary Calcium Scores Benefit From Statin Treatment A Post Hoc Analysis From the St. Francis Heart Study. JACC-CARDIOVASC IMAG 2012;5 (3):252-260 [PubMed]
Mulders TA, van den Bogaard B, Bakker A, Trip MD, Stroes ES, van den Born BJH, Pinto-Sietsma SJ, Arterial stiffness is increased in families with premature coronary artery disease. HEART 2012;98 (6):490-494 [PubMed]
Nieuwkerk PT, Nierman MC, Vissers MN, Locadia M, Greggers-Peusch P, Knape LPM, Kastelein JJP, Sprangers MAG, de Haes HC, Stroes ESG, Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk. AM J CARDIOL 2012;110 (5):666-672 [PubMed]
Rensing KL. Insulin and insuli-like growth factor-I. Two of a kind in the development of cardiovascular disease?. s.l.: s.n.; 2012. 204p. ISBN 9789462032095 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): Twickler TB, von der Thüsen JH)
Rensing KL, von der Thüsen JH, Weijers EM, Houttuijn Bloemendaal FM, van Lammeren GW, Vink A, van der Wal AC, van Hinsbergh VWM, van der Loos CM, Stroes ES, Koolwijk P, Twickler TB, Endothelial insulin receptor expression in human atherosclerotic plaques: Linking micro- and macrovascular disease in diabetes?. ATHEROSCLEROSIS 2012;222 (1):208-215 [PubMed]
Reuwer AQ, Sondermeijer BM, Battjes S, van Zijderveld R , Stuijver DJF, Bisschop PH, Twickler MTB, Meijers JCM, Schlingemann RO, Stroes ES, Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study. PITUITARY 2012;15 (4):472-481 [PubMed]
Sondermeijer BM. Cardiovascular metabolism. s.l.: s.n.; 2012. 201p. ISBN 9789088914782 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Stroes ESG; copromotor(s): Serlie MJM)
Sondermeijer BM, Klein Twennaar CF, Kastelein JJP, Franssen EJF, Hutten BA, Dallinga-Thie GM, Stroes ESG, Fliers E, Twickler MTB, Serlie MJ, Infusion of a Lipid Emulsion in Healthy Men Decreases the Serotonergic Response. NEUROENDOCRINOLOGY 2012;95 (4):325-331 [PubMed]
Stuijver DJF, van Zaane B, Gerdes VEA, Stroes ES, Schildklierdiagnostiek bij dyslipidemie. NED TIJDSCHR GENEESKD 2012;156 (2):A4301 [PubMed]
Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Péterfy M, Kastelein JJP, Johansen CT, Hegele RA, Stroes ESG, Dallinga-Thie GM, Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J INTERN MED 2012;272 (2):185-196 [PubMed]
van den Bogaard B. Central hemodynamics and arterial function. S.l.: s.n.; 2012. 248p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): van den Born BJH, van Montfrans GA)
van den Bogaard B, Holleboom AG, Duivenvoorden R, Hutten BA, Kastelein JJP, Hovingh GK, Kuivenhoven JA, Stroes ESG, van den Born BJH, Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness. ATHEROSCLEROSIS 2012;225 (2):481-485 [PubMed]
van der Valk FM, van Wijk DF, Stroes ESG, Novel anti-inflammatory strategies in atherosclerosis. CURR OPIN LIPIDOL 2012;23 (6):532-539 [PubMed]
van der Valk FM, van Wijk DF, Stroes ESG, Serendipity of post-hoc surrogate marker research. EUR HEART J 2012;33 (23):2897-2898 [PubMed]
van Leuven SI, Mendez-Fernandez YV, Wilhelm AJ, Wade NS, Gabriel CL, Kastelein JJ, Stroes ES, Tak PP, Major AS, Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr-/- mice. ANN RHEUM DIS 2012;71 (3):408-414 [PubMed]
Visser ME, Dallinga-Thie GM, Pinto-Sietsma SJ, Defesche JC, Stroes ES, van der Valk PR, APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required. NETH J MED 2012;70 (6):278-280 [PubMed]
Visser ME, Wagener G, Baker BF, Geary RS, Donovan JM, Beuers UHW, Nederveen AJ, Verheij J, Trip MD, Basart DCG, Kastelein JJP, Stroes ESG, Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial. EUR HEART J 2012;33 (9):1142-1149 [PubMed]
Visser ME, Witztum JL, Stroes ESG, Kastelein JJP, Antisense oligonucleotides for the treatment of dyslipidaemia. EUR HEART J 2012;33 (12):1451-1458 [PubMed]
Vrieze A , van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JFWM, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, van Hylckama Vlieg JET, Bloks VW, Groen AK, Heilig HGHJ, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JBL, Nieuwdorp M, Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome. GASTROENTEROLOGY 2012;143 (4):913-+ [PubMed]
Bisoendial RJ, Stroes ESG, Tak PP, Critical determinants of cardiovascular risk in rheumatoid arthritis. CURR PHARM DESIGN 2011;17 (1):21-26 [PubMed]
Broekhuizen LN. Glycocalyx, cardiometabolic disease and inflammation. S.l.: s.n.; 2011. 183p. ISBN 9789461082008 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Vink H; copromotor(s): Stroes ESG, Nieuwdorp M)
Broekhuizen LN, Boekholdt SM, Arsenault BJ, Despres JP, Stroes ESG, Kastelein JJP, Khaw KT, Wareham NJ, Physical activity, metabolic syndrome, and coronary risk: the EPIC-Norfolk prospective population study. EUR J CARDIOV PREV R 2011;18 (2):209-217 [PubMed]
Broekhuizen LN, van Wijk DF, Vink H, Stalmach A, Crozier A, Hutten BA, Kastelein JJP, Hugenholtz PG, Koenig W, Stroes ESG, Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors. BRIT J NUTR 2011;106 (9):1416-1422 [PubMed]
den Ruijter HM, Franssen R, Verkerk AO, van Wijk DF, Vaessen SF, Holleboom AG, Levels JH, Opthof T, Sungnoon R, Stroes ES, Kuivenhoven JA, Coronel R, Reconstituted High-Density Lipoprotein Shortens Cardiac Repolarization. J AM COLL CARDIOL 2011;58 (1):40-44 [PubMed]
Duivenvoorden R, Holleboom AG, van den Bogaard B, Nederveen AJ, de Groot E, Hutten BA, Schimmel AW, Hovingh GK, Kastelein JJP, Kuivenhoven JA, Stroes ESG, Cholesterol Acyltransferase Gene Mutations Have Accelerated Atherogenesis as Assessed by Carotid 3.0-T Magnetic Resonance Imaging Carriers of Lecithin. J AM COLL CARDIOL 2011;58 (24):2481-2487 [PubMed]
Franssen R, Monajemi H, Stroes ESG, Kastelein JJP, Obesity and dyslipidemia. MED CLIN N AM 2011;95 (5):893-902 [PubMed]
Holleboom AG. Genetic disorders of HDL metabolism: from model to mechanism. s.l.: s.n.; 2011. 422p. ISBN 9789461081735 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG, Kastelein JJP; copromotor(s): Kuivenhoven JA, Hovingh GK)
Holleboom AG, Karlsson H, Lin RS, Beres TM, Sierts JA, Herman DS, Stroes ESG, Aerts JM, Kastelein JJP, Motazacker MM, Dallinga-Thie GM, Levels JHM, Zwinderman AH, Seidman JG, Seidman CE, Ljunggren S, Lefeber DJ, Morava E, Wevers RA, Fritz TA, Tabak LA, Lindahl M, Hovingh GK, Kuivenhoven JA, Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. CELL METAB 2011;14 (6):811-818 [PubMed]
Holleboom AG, Kuivenhoven JA, Peelman F, Schimmel AW, Peter J, Defesche JC, Kastelein JJP, Hovingh GK, Stroes ES, Motazacker MM, High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations. HUM MUTAT 2011;32 (11):1290-1298 [PubMed]
Holleboom AG, Kuivenhoven JA, van Olden CC, Peter J, Schimmel AW, Levels JH, Valentijn RM, Vos P, Defesche JC, Kastelein JJP, Hovingh GK, Stroes ESG, Hollak CEM, Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase. ATHEROSCLEROSIS 2011;216 (1):161-165 [PubMed]
Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK [Contributors: Absenger G, Albrich E, Allinger B, Allinger S, Anacher G, Angermayr G, Angermeier H, Anzengruber A, Archimanitis G, Arnsteiner P, Auberger W, Azhary M, Barfuss M, Bauer C, Bauer BE, Beclin T, Binder T, Binder G, Böhler D, Brändle J, Breslmair J, Brettlecker M, Bürger M, Calvi I, Dorfinger W, Doringer-Schnepf E, Eer A, Eckmayr C, Eder F, Egermann M, Erath M, Etzinger M, Etzinger C, Fiedler L, Filip W, Filip M, Föchterle J, Fodor A, Frieden T, Gareiss M, Gföllner P, Ghamarian T, Goritschan M, Haar K, Habeler G, Hadjiivanov V, Haiböck C, Hammer R, Hartmann S, Haschkovitz H, Hauer W, Hauer J, Haunschmidt C, Heimayr C, Hengl W, Hengl G, Hermann R, Herrmann R, Hillebrand R, Hintersteininger O, Hirsch M, Hitzinger M, Hochegger T, Hockl W, Hoi M, Hörmann J, Hudler B, Imb G, Joichl A, Jungbauer K, Kapl G, Kerschbaum M, Kienesberger F, Killinger G, Kitzler G, Klein F, Kleinbichler D, Kohr A, Kopetzky M, Korthals C, Kortschak W, Koschutnik M, Kraus WA, Kurzemann S, Lavicka C, Lehner G, Lenz J, Lepuschütz S, Lichtenwallner M, Lober R, Loidl C, Lopatka E, Ludwig R, Maca T, Mair A, Mandak M, Margreiter M, Margreiter A, Markovics M, Matejicek F, Mohilla M, Moll C, Mörz B, Mörz R, Nagl H, Neumayr G, Oberroitmair H, Oberzinner M, Pallamar W, Pangratz S, Parandian L, Paulus A, Pfaffenwimmer C, Plaichinger P, Pokorn T, Polanec H, Pöll-Weiss B, Pralea D, Puttinger J, Quinton T, Ranegger M, Rass S, Rauch H, Riehs M, Robetin E, Rohringer J, Rupprechter J, Sadjed E, Schimbach JA, Schmid J, Schneiderbauer R, Schopper W, Schulze-Bauer A, Schuster G, Schwarz J, Schwarz M, Schweighofer C, Schwelle F, Simma H, Sock R, Sock R, Sprenger F, Stiglmayr T, Stocker I, Stütz P, Tama M, Teleky U, Tschauko W, Veits M, Vikydal G, Vlaschitz K, Wais E, Wais A, Wegmann R, Wehle F, Weindl M, Weinhandl M, Wendt U, Wendt K, Werner-Tutschku V, Werner-Tutschku C, Wilscher J, Wind N, Winter A, Wolfschütz G, Wolfsgruber M, Wolfsgruber B, Wurm R, Ziebart-Schroth A, Zimmermann M, Zinnagl A, Zirm A, Zirm Canada B, Bokenfohr GM, Liu EKH, Melling GW, Papp EW, Sachdeva AK, Snyman ER, Varma S, Ward RA, Tiong Wong AP, Basson PJ, Brodie BD, Chahal SJ, Chan WY, Chow JC, Cormack M, Eddy DHJ, Ezekiel D, Farquhar A, Gu S, Hii TH, Ho-Asjoe MPK, Hosie A, Jaffer S, Jakubowski AT, Karim M, Kiai C, Kooy J, Lytle CR, Mcleod KL, Morgan DC, Myckatyn MM, Ng JPY, Schriemer R, Schumacher G, Grey Stopforth J, Hoo Tsui WW, Wilson RT, Wong D, Wong WT, Yeung MMW, Cram DH, Kumari Dissanayake DT, Gerber JDW, Haligowski D, Hrabarchuk B, Kroczak TJ, Lipson AH, Mahay RK, Wessels Mare AC, Mohamdee FJ, Olynyk FT, Pieterse W, Ramgoolam R, Rothova A, Saunders KK, Szajkowski S, van Gend RF, van Rensburg NMJ, Anand S, Baer CEH, Basque EJY, Benaya S, Bessoudo R, Bhalla J, Chettiar NV, Craig BN, Desrosiers F, Ranjani Imbulgoda M, Morgan GM, Nowak ZJ, Scott DG, Searles GR, Slorach JN, Stevenson RN, Browne NJ, Bruff KJ, Collingwood JM, Collins W, Over A, Gabriel AM, Govender M, Hart DG, Hatcher LB, Janes J, Kielty JF, Krisdaphongs M, Lush RB, Moulton WB, Riche CR, Rideout GM, Roberts BC, Walsh PE, Wight HG, Woodland KH, Woodland RC, Atkinson BC, Chow CSHA, Collins JA, Graham RD, Hosein J, Machel TM, Mahaney GR Jr, Mclean JRB, Murray MR, Myatt GA, Ozere CP, Saha AK, Sanders DH, Seaman DM, Seaman JG, Swinamer D, Voon Yee KY, Ali MM, Bankay CDC, Beduhn EER, Callaghan DJ, Chan YK, Chaudhri AR, Chen RYY, Conway JR, Cunningham WL, Cusimano SL, Souza ED, de Souza SX, Deyoung JP, Epstein R, Faiers AA, Figurado VJ, Forbes FBT, Gabor Z, Gallardo RC, Gaur SK, George E, Hartford BJ, Shiu-Chung Ho M, Ho C, Ismail SH, Bhushan Kalra B, Koprowicz K, Kumar N, Lam C, Lau MJ, Law HKC, Fung MLS, Liutkus JF, Lotfallah TK, Luton RG, Meneses GS, Miller ML, Nagji N, Ng KHM, Ng Thow Hing RE, Pandey AS, Petrov I, Rosenthall W, Rudner H, Russell AD, Sanchez ZA, Shaban JA, Shariff SBK, Shih CM, Sinclair DW, Spink DR, Tung THT, Vizel S, Yanover DF, Zavodni LS, Cusack P, Dewar CM, Hooley P, Kassner RA, Mackinnon RJ, Molyneaux HW, Shetty KN, Barrière G, Berjat MB, Bernucci B, Bérubé C, Boueau G, Chehayeb R, Ciricillo D, Constance CM, Côté G, Desroches J, Gagnon R, Gaueau G, Godbout JL, Harvey P, Hassan Y, Hoang NV, Houde D, Lalonde AP, Lavoie R, Leclair N, Meagher L, Ouimet A, Plourde S, Rioux DW, Roberge C, Roy B, Sasseville R, Serfaty S, Theriault L, Timothée JR, Tjia S, Tremblay B, Turcotte J, Bose S, Aletta Bouwer H, Chernesky PA, Johnson ML, Kemp DR, Lai RPC, Lee FR, Lipsett WGC, Lombard SJ, Majid FS, Malan JJ, Maree N, Nayar A, Nel M, Oduntan OO, Rajakumar ARJ, Baraka Ramadan F, Shamsuzzaman M, Vermeulen APM, Fred C, Anthonsen B, Ardest SP, Arnold-Larsen SK, Axelsen A, Barfoed K, Birkler NE, Blokkebak J, Boserup J, Kettrup Brassøe JO, Chovanec M, Lykke Christensen B, Christensen M, Skjøth Christensen R, Eidner PO, Eisbo J, Elsvor J, Engmann IVC, Eriksen RM, Frederiksen T, Frølund HC, Garne S, Giørtz A, Gregersen B, Halkier ML, Hansen JG, Harder J, Jørgen H, Henriksen O, Kirkeby Hoffmann M, Holk E, Hollensen J, Jacobsen R, Jakobsen L, Jensen C, Jensen M, Jensen V, Jepsen P, Johannsen JA, Verner Johansen L, Johansen OS, Juul K, Jørgensen AF, Jørgensen P, Jørgensen UM, Kensmark L, Kjellerup C, Kjaer E, Kjaersgaard M, Klubien P, Kolby P, Korsgaard Thomsen K, Krebs P, Kristiansen T, Lyng F, Madsen NV, Meyer-Christensen J, Mogensen O, Mortensen F, Nielsen LM, Nielsen PS, Nielsen SK, Ommen H, Juhl Otte J, Østergaard Paridon V, Parm M, Peampour K, Petersen K, Pilgaard PJ, Poulsen SE, Preisler T, Hast Prins SU, Randløv A, Rasmussen BR, Elmegaard Rasmussen P, Rasmussen R, Roed SF, Sander KF, Schmidt EØ, Jørgen Schultz P, Smidemann M, Solgaard J, Stripp T, Søderlund MRM, Søgaard H, Søndergaard DE, Sørensen BH, Sørensen GS, Thøgersen N, Toftdahl H, Uggerhøj H, Uhrenholt B, Veronika Ullisch E, Valentiner-Branth C, Vinberg J, Vinter SA, Vittrup P, Winther-Pedersen N, Wøldike AG, Zederkof JM, Thue Østergaard M, Abiven P, Abraham D, de Beaumais PA, Ado JP, Affres H, Agache R, Airault Leman AM, Moussarih AA, Albaric C, Allaouchiche T, Allignol C, Ammor M, Ammoun Bourdelas C, Amsallem L, Anquez D, Antonini JM, Assuied V, Attia G, Audebert O, Audibert H, Ayach C, Bagdadlian S, Bagni M, Baillet J, Ballivian Cardozo F, Baranes R, Barbier P, Barousse F, Bas S, Battaglia JM, Baudonnat B, Bauple JL, Domengetroy FB, Beard T, Beaumier E, Beaumont JF, Baylac Domengetroy F, Beck C, Behar M, Behr B, Benady R, Benghanem MM, Benichou H, Bensoussan JM, Bensussan P, Bercegeay P, Berneau JB, Bertolotti A, Bertrand S, Besson A, Bezanson C, Bezier C, Bezzina R, Bichon H, Bickar P, Billot P, Billot Belmere MC, Bisson F, Blanc D, Bloch JL, Bloch B, Blondin H, Blot J, Bloud R, Blouin P, Boesch C, Boiteux JL, Bonnafous P, Bonneau Y, Bonnefoy L, Borg B, Borys JM, Brunehaut Petaut M, Boschmans S, Said RB, Bouallouche A, Bouchet J, Bouchlaghem K, Boulen Y, Bouline B, Bounekhla MS, Bouquin V, Bourgeois MB, Bourgois D, Brandily C, Brandt P, Branquart F, Breilh P, Brilleman F, Brisson T, Brocard F, Bruel P, Brun JP, Buisson JG, Buisson Virmoux I, Bur C, Cabal Malville E, Cabantous S, Cabrol P, Cagnoli Gromovoi S, Caillaux BX, Caillot D, Canchon Ottaviani I, Canu P, Caramella A, Caramella A, Cardaillac C, Carrivale A, Cartal JP, Cassany B, Cauon B, Causeret JM, Caye P, Cayet JP, Cazor G, Cesarini J, Chakra G, Chambeau B, Chambon V, Chanas J, Chapuzot P, Charon A, Charpin E, Charton F, Cheikel J, Chemin P, Chennouf K, Chequel H, Chevrier D, Ciroux P, Cissou Y, Claeys JL, Clariond Y, Classen O, Cloerec A, Clouet S, Cloup Lefeuvre AM, Cochet C, Cocuau D, Cohen H, Cohen Presberg PC, Colin S, Colin R, Colucci R, Come P, Condouret P, Conturie A, Corbin A, Corticelli P, Coste D, Cotrel O, Coueau S, Coulon P, Courdy C, Courtin M, Courtot P, Coutrey L, Couval R, Cravello P, Cressey O, Cuisinier Y, Cunin B, Cunnington B, Cusseau H, Cuvelier C, Arailh BD, Dabboura A, Dages L, Dahmani N, Dandignac JC, Daney D, Dannel B, Darbois D, Dareths P, Daubin D, David JC, de Foiard P, de Mallmann Guyot VD, de Wit MA, Debast F, Deboute E, Debuc JP, Dechoux E, Decloux O, Decruyenaere Y, Dejans JM, Delarue M, Delattre X, Delmaire P, Denis L, Deschamps Ben Ayed M, Devins P, Dezou S, Dieuzaide P, Dirheimer B, Dominguez P, Donadille F, Dondain B, Doridan P, Ouhet P, Dubois A, Dubois A, Ducharme P, Duchez P, Dulard C, Dumoulin M, Duprey G, Durand J, Mohamed I, Chehab E, Emery B, Emmanuel G, Ashari GE, Evrard E, Fargeot Lamy A, Farges JL, Faucher P, Faucie A, Faure Y, Favre JJ, Felipe JL, Feret D, Ferragu A, Ferrandin G, Ferriot F, Finelle L, Flond J, Foieri J, Fol S, Fontaine B, Forichon D, Foucry M, Fournier JF, Fregeac B, Fuchs M, Gabriel F, Gaimard D, Gallois S, Garapon G, Garas M, Garcia P, Garcia JM, Garcia MP, Garman W, Garzuel D, Gaspard JM, Gauci L, Gautheron P, Gauthier J, Gauthier Lafaye PY, Gay MC, Gay Duc B, Gayout O, Gegu Y, Gentile F, Germain E, Gharbi G, Gigandet Tamarelle C, Gilardie A, Gilles Verliat M, Gillet T, Gnana P, Goguey A, Gombert A, Gonin B, Gonzales P, Goulesque X, Graba JM, Granier A, Greiner O, Groboz M, Gromoff S, Grossemy X, Grossi C, Guenin F, Gueranger P, Guerin P, Guerineau JP, Guessous Zghal F, Guicheux D, Guillere J, Guyonnet G, Haddad S, Hadj N, Hamani D, Hamm J, Hammoudi D, Harle X, Harnie Coussau P, Hazen R, Hembert F, Hemon P, Hergue M, Hestin C, Heyraud L, Hindennach D, Hirot E, Ho Wang Yin CS, Hocquelet Denis C, Hoppe P, Horovitz D, Hours JM, Houta B, Hua G, Hui Bon Hoa N, Humez P, Hurier M, Husson G, Hyvernat G, Ichard JF, Impens C, Iovescu D, Jacob P, Jacob G, Jacquemart JP, Jacquier P, Jahanshahi Honorat S, Jalladeau JF, Jan L, Jannel Y, Jarrige V, Jeremiasz R, Annick Jestin Depond M, Joseph M, Joseph Henri Fargue H, Joubrel A, Jouet A, Julien B, Jullien F, Jullien JL, Kadoche D, Kahl E, Kanawati A, Khalife S, Khettou C, Kiers JP, Kissel C, Klein JC, Klopfenstein S, Koch A, Koenig G, Kohler P, Koriche A, Labernardiere N, Labet P, Lablanche F, Laborde Laulhe V, Lagorce X, Laine E, Lalague P, Laleu JN, Lambert M, Lambert Ledain ML, Lambertyn X, Lame JF, Langlois F, Lanoix E, Laprade M, Lasseri C, Laterrade B, Laurent JC, Laurier B, Laval L, Le Borgne P, Le Franc P, Le Henaff P, Le Noir de Carlan H, Le Roy JP, Le Roy Hennion F, Lebon L, Lecler O, Leclerc P, Ledieu C, Lefebvre B, Lefevre P, Lehujeur C, Leiber C, Leick G, Lemberthe T, Lenevez N, Lenoble P, Leriche P, Leroux E, Leroy JM, Leroy C, Lescaillez D, Leurele C, Lhermann S, Libermann P, Licari G, Lo Re A, Long P, Long JL, Lormeau B, Louchart JC, Lucas JP, Luquet T, Lussato P, Maarouf M, Mabilais F, Magnier Sinclair C, Mahot Moreau P, Malafosse D, Mandirac JP, Manolis J, Mante JP, Maquaire C, Marchal T, Marchand G, Marillesse O, Marmier G, Herve Maron Y, Marrachelli N, Marsaux M, Martin B, Martin M, Deiss PM, Masson A, Mativa B, Matton JF, Mauffrey J, Mauriere S, Maurois G, Maury J, Mayer F, Menu P, Mercier B, Messmer D, Mestiri S, Meyer G, Michaelides M, Michaud G, Michenaud B, Mielot S, Millory Marco JA, Mingam S, Mira R, Mius S, Monnier Meteau MP, Mora F, Morbois Trabut L, Morosi L, Mougeolle JL, Mouget JL, Mouroux D, Mouthon JM, Muller J, Nakache A, Narbonne H, Navarranne Roumec A, Navarro P, Neubrand JY, Nguyen QT, Nguyen Quang G, Nguyen Xuan T, Niot P, Oudart JM, Outteryck A, Pages JM, Paillet C, Pain JM, Pangaud de Gouville P, Paquin O, Parent V, Parer Richard C, Parrot F, Parthenay P, Pascariello JC, Passebon JC, Pere A, Perelstein L, Perot M, Petit R, Petit P, Petit F, Petruzzi P, Phelipeau D, Philippon JC, Philippon G, Picard B, Picard JC, Picot B, Piera JF, Pieri A, Piffoux E, Pilard P, Pillet A, Pinot P, Pinzani A, Pleskof A, Plessier JC, Plisson A, Pochon C, Poggi V, Poirat A, Poiree M, Polleux J, Noel Pontecaille J, Posocco R, Pospiech JC, Pradies F, Prevot R, Pueyo JB, Quaelli J, Rabbia M, Rabemananjara A, Rami S, Rapin JJ, Rasquin C, Ratinaud D, Reboud B, Reboul P, Reichman JJ, Reinhardt P, Renard Houta CR, Reverdy O, Revol M, Rey PA, Richardeau Y, Rives B, Robida C, Rochez Fraiberg M, Rodet JP, Rolland JF, Romand B, Romano JP, Rosati Gretere C, Rosey A, Rosset M, Rossi JP, Rouquette G, Rousseau M, Rousselon X, Roy C, Royer D, Ruetsch M, Saade M, Saby Kuchler N, Samar G, Sanchez PY, Sane A, Sanz JP, Sardon M, Sarrazin ME, Sasportes G, Saudou F, Sauze E, Savary P, Schenowitz A, Schmartz P, Schoepfer MO, Seewagen J, Serramoune D, Serre C, Sicard Guroo H, Sichãc JP, Sifaoui S, Simoncello M, Simonin MJ, Simonnet JF, Spindler D, Steier A, Sultan CR, Taghipour K, Talayrach B, Talbot F, Talhouarn V, Tallec Y, Tarasco Schenrey E, Tarrene M, Tater D, Tessier B, Teste M, Thierry D, Thiollier P, Thoreau F, Thual J, Traen V, Trigano JA, Troussier JB, Truong Ky Minh B, van Melckebeke G, Vaque P, Vaucelle C, Vedel E, Venu D, Verdavoine P, Vergeron J, Viallon P, Viault D, Vieules JM, Vigier JP, Vilain JM, Villard B, Vitoux JF, Viviand P, Vivien O, Walter P, Waquier P, Waszkiewicz JM, Weidich S, Westerfeld R, Weynachter G, Wilhelm P, Wolff C, Wursthorn M, Zammattio D, Zylinski B, Lauer P, Kühn U, Weltzel W, Mohr H, Weyland K, Spittel B, Böhm G, Ferdowsy S, Hanusch P, Spiekermann J, Albert E, Stuff K, Jungmair W, Koller S, Schubert W, Schlehahn F, Bormann G, Graf K, Stiehler G, Bock M, Müller A, Haufe M, Nielsen L, Raum D, Rogler K, Bürstner J, Völk HJ, Sachse M, Escher T, Doumit A, O'dey H, Holzmann U, Sauer H, Schellenberg G, Carius J, Dänschel W, Kopf A, Zerr E, Tatalovic R, Rupp H, Anders E, Mende M, Volk U, Hagenow A, Lang T, Schmitz KH, Gössling JH, Mutsch G, Steidel J, Osten K, Giokoglu K, Bellisch S, Füll K, Walther W, Flick S, Dünnebier R, Dharmawan I, Schönmehl W, Hoss V, Kipping S, Wolf HJ, Wolf HF, Willmann V, Bugarski B, Hoffschröer J, Von Wallfeld S, Ruhland G, Bulling D, Häusler M, Haustein G, Kallenbach C, Schwemmler C, Frank A, Lodder-Bender U, Rawe K, Reinert HF, Schönhof P, Fahrenschon K, Schorcht E, Etzold E, Brehm M, Paust WD, Schulte-Kemna A, Pötter KW, Ott-Voigtländer U, Schwenke R, Thinesse-Mallwitz M, Siml S, Stern H, Roelen H, Scherhag KP, Matulla P, Herrmann HJ, Neumann G, Barbuia M, Vormann R, Hitzler K, Linum A, Hanke K, Hohberg HJ, Klingel R, Hohnstädter R, Klasen H, Aschermann P, Grau W, Killinger P, Gross K, Naus R, Todoroff K, Zühlke W, Kellner HU, Hager E, Thieme J, Kornitzky M, Rösch V, Heinze E, Hiederer W, Konz KH, Köhler M, Diekmann M, Junghans E, Dietermann F, Kerp E, Schäfer-Lehnhausen S, Kruck I, Ettelt R, Hölscher A, Kittler S, Jung H, Mailänder A, Nowara P, Ritschl H, Mödl B, Gallwitz T, Meyer S, Peter A, Peters O, Pflaum P, Fröhlich KH, Mertens HJ, Merlin-Sprünken V, Erpenbach K, Fervers F, Kuhl U, Halsig F, Rein W, Hauser ER, Laubenthal F, Richard F, Langer C, Lange R, Eska J, Mohanty G, Lange I, Eltges N, Kuntz C, Mechery T, Vöckl J, Viergutz C, Stähle-Klose C, Sohr K, Böhler S, Brecke G, Burls M, Werner KM, Vorpahl R, Stahl-Weigert B, Bunge G, Thomsen J, Blessing E, Bengel B, Buhlmann U, Tröger T, Sippel S, Vossschulte V, Wilms W, Appelt A, Dauterstedt D, Witte W, Böttger U, Wyborski W, Strache S, Böttger W, Zeiner L, Wuttke W, Stoidner- Amann A, Stoermer B, Bock S, Groos-März C, Thamm ME, Meier J, Schneider M, Niessen U, Storm GR, Streitbürger E, Münkel T, Palfi M, Naumann U, Tannhof G, Streibhardt F, Gebhardt W, Nieswandt G, Gerke U, Nöhring A, Bott J, Goertz J, Winkler D, Lotter E, Kraaz K, Bärwinkel P, Hildebrandt D, Weyers G, Kubin-Siring B, Baier E, Weber T, Holz DE, Wolfers J, Kihm W, Kamali-Ernst S, Amann W, Kaase HJ, Banning O, Voigt T, Grünert F, Gürtler M, Pferdmenges K, van Treek H, Möller B, Weigel S, Jun Hassler N, Mauer H, Beckers E, Weber CA, Hawash H, Ladke D, Labitzky G, Kunkel P, Hartung W, Pomykaj T, Prokop H, Schleif T, Cascino L, Exner P, Daelman E, Dietrich A, Prasse T, Brundisch S, Schipper R, Duderstaedt B, de Haan F, Schmidt-Reinwald A, Seidel P, Schmitz J, Bülent E, Ja Pique P, Ding R, Eggeling T, Duderstaedt E, Ferchland HP, Kruth R, Gralla D, Köhler A, Laborge JR, Hammer H, Richter I, Sauldie H, Valk-Denkema IVD, van der Valk L, Feely J, Dunne L, Cox J, Doyle M, O'Gorman M, Kennedy J, Maher B, Forde D, Harrington P, Cronin B, Coady A, Craig J, O'Dowd C, O'Doherty B, O'Connor P, Ling R, Perry M, Crowley J, Keaveney L, Townley E, O'Shea E, Regan M, Cunningham S, Bluett D, Whyte O, Casey M, Ruane F, Fitzgerald E, O'Beirn E, Faller E, Moffatt S, Coleman M, Day B, Mcadam B, O'Neill D, Mac Mahon C, Wheeler M, Byrne S, Fulcher K, CAREY O, O'Connell K, Keane J, Almarsomi L, Vaughan C, O'Callaghan T, Grufferty T, Shanahan E, Crowley B, Moran J, Cotter J, Healy C, Curtin T, Dillon J, Dennehy T, Murphy E, Kennedy M, Coffey D, Carroll PO, Oliver B, Mccarthy S, Joyce P, O'Shea G, Apperloo AJ, Basart DCG, Bax M, Beysens PAJ, Breed JGS, Derks A, Eijgenraam JW, Hermann JPR, Janus CL, Kaasjager HAH, Klomps HC, Koole MAC, Koster T, Kroon C, Lieverse AG, Massaar-Hagen BEM, Moghaddam F, Oldenburg-Ligtenberg PC, Potter van Loon BJ, Stroes ESG, Twickler TB, van Asperdt FGMH, van Asseldonk JPM, van der Loos TLJM, van der Velde RY, van der Vring JAF, van Dorp WT, van Essen GG, van Kalmthout PM, van Liebergen RAM, van Wissem S, Waanders H, Withagen AJAM, Andersen PVK, Andersen RF, Andersson E, Arnstad A, Belguendouz L, Birkeland IA, Bjørkum K, Bredvold T, Brevig LH, Buchman E, Burkeland-Matre R, Burski K, Byre R, Bø PE, Dahl E, Duch A, Duong K, Dvergsdal P, Edvardsen M, Ernø A, Fredwall SO, Glasø M, Glasø J, Grini A, Hallaråker A, Normann Hansen AN, Haugland HH, Henrichsen SH, Hestnes A, Idehen NIE, Jacobsen KL, Johansen T, Johnsen R, Jonasmo K, Kirknes S, Kjetså A, Kjaer P, Knoph E, Knutssøn C, Koss A, Kravtchenko O, Krogsæter D, Langaker K, Lind KW, Lund KR, Madsbu S, Mehlum YEM, Moon P, Movafagh A, Myhrer K, Nørager DM, Ore S, Rafat HB, Rød R, Schmidt-Melbye T, Singh N, Singsås T, Skjelvan G, Smet A, Staalesen S, Storeheier E, Storhaug S, Storm-Larsen A, Sundby JE, Syverstad DE, Sørensen AS, Torjusen TB, Torkelsen A, Tunby JR, Vanberg PJ, Vevatne A, Vikse A, Wahlstrøm V, Walaas K, Walløe AE, Wear-Hansen HG, Ole Ystgaard OA, Zimmermann B, Øvsthus K, Aião J, Albuquerque M, Alves F, Esteves A, Amaral MF, Amaral F, Amorim H, Anade B, Anade MB, Antonio G, Araujo F, Arriaga A, Baeta S, Afonso FB, Beato V, Beirão P, Martins AB, Bernardes J, Botas L, Baeta A, Ramos MB, Brandão P, Brandão AG, Brandão A, Raposo AC, Carrilho F, Carvalho I, Carvalho P, Castel-Branco A, Castellano MD, Corredoura A, Corredoura AS, Costa V, Coutinho J, Crujo F, Cunha D, Dias M, Fernandes ME, Ferreira G, Ferreira D, Ferreira J, Ferreira AM, Fonseca A, Freitas P, Gago A, Galego R, Garrett AV, Gavina C, Simões JG, Gomes MF, Gomes N, Gomez B, Graça P, Gravato A, Guedes NF, Guerra F, Issa C, João IF, João I, Jorge V, Leite MS, Lousada N, Macedo FM, Madeira Lopes J, Magalhães J, Marinho JC, Marques C, Marques JA, Marques Ferreira A, Martins JC, Martins JB, Matos A, Melo M, Miguel A, Monteiro F, Monteiro F, Monteiro FB, Sarmento JM, Morato Sá MJ, Mota J, Moura L, Moura B, Neves L, Neves C, Oliveira M, Oliveira Ramos M, Osorio R, Pacheco J, Palma I, Peixoto MC, Pereira H, Pestana J, Pignatelli D, Pinho H, Puig J, Raindo M, Ramos H, Rebelo M, Roigues A, Roigues A, Roigues E, Rola J, Rovytchcva M, Sa J, Santos F, Santos JC, Sequeira Duarte J, Serra E Silva P, Silva B, Silva P, Silva M, Silva F, Silva D, Silva J, Silvestre I, Simões H, Soares M, Sousa N, Sousa A, Souto D, Teixeira E, Torres I, Valle T, Ventura C, Vicente A, Vieira M, Alfaro R, Alonso R, Alvarez JC, Allut G, Amado JA, Ampuero J, Angel LF, Antolín E, Anton J, Aranda JL, Argimon J, Arques F, Arribas JP, Arroya C, Arroyo JA, Auladell MA, Bajo J, BALVIN A, Ballester JV, Barreda Glez MJ, Becerra A, Bermejo JC, Bernacer L, Besada R, Blasco J, Bravo M, Bueno FM, Campo I, Carrasco JL, Catalán JI, Cobo J, Coello I, Combarro J, Contreras JA, Correa J, Cortilla A, Cuatrecasas G, Chicharro S, de Dios J, de Los Arcos E, de Portugal J, del Cañizo F, del Molino F, Díaz JL, Domingo J, Escobar C, Escoda J, Espinosa E, Ester F, Fernandez A, Ferreiro M, Fondas JM, Fraile AL, Franco M, Fuentes F, Garcia JA, Garcia D, Garcia ME, García L, Garcia J, Gilabert R, Goiria B, Gomez P, Gomez-Calcerrada D, Gonzalez M, Gonzalez JM, Guijarro C, Guirao Gujarro V, Herrera C, Herrera MC, Herrero M, Ibarguren A, Irigoyen L, Jimenez B, Lamelas JA, Laplaza I, Laporta F, Lazo V, Leal M, Ledesma V, Lopez P, Lopez P, Lopez A, López MJ, Lopez-Cepero E, Lorenzo F, Lucena J, Luquín R, Lloveras A, Maceda T, Macia R, Marti C, Martin JM, Martin I, Martín Lesende I, Martinez M, Martinez JA, Martinez P, Martinez A, Mato F, Medel F, Mederos AM, Mediavilla J, Mediavilla G, Mestron A, Michans A, Millán J, Molina C, Monroy C, Monte I, Montes JM, Morales C, Morales FJ, Morata C, Mori C, Muñoz J, Muñoz MJ, Núnez J, Nuñez A, Ocaña F, Olaz F, Ollero Artigas A, Ortega J, Oteo O, Pascual JM, Paya JA, Pechuan J, Penedo Suarez R, Perez E, Pesquera C, Pia G, Piea M, Pinilla M, Pita A, Pose A, Prieto Díaz MA, Quesada C, Ramirez F, Ramirez C, Ramirez L, Reinares L, Rey S, Ribas M, Ridaura A, Ridocci F, Rigueiro P, Rivera S, Robles A, Rodero E, Roiguez JA, Romero F, Romero Hernandez F, Romeu R, Rubio Buisán L, Salas F, Sánchez C, Sánchez J, Saponi JM, Serres M, Suarez S, Suarez C, Tato M, Tebar FJ, Toda MR, Tofe S, Urdiain R, Vaamonde L, Valderrama J, Vazquez JA, Velazquez O, Venell F, Vilariño R, Villa MJ, Villar MD, Zarauza J, Zuñiga M, Abab JL, Abad E, Abad R, Afonso C, Aguilar G, Alberiche MDP, Alcolea R, Alegria E, Almagro F, Almenara A, Almenos MC, Alonso J, Alvarez M, Ampudia J, Andia VM, Anglada J, Aranda MÁ, Arbelo L, Armengol F, Arnau A, Arrarte V, Arribas B, Artiñano Y, Avilés B, Ayensa J, Ballestar E, Ballester J, Barcelo B, Barcena F, Barranco M, Barrena I, Barriales V, Barrot J, Bartolome JA, Belmonte J, Bellés A, Benito J, Bernad A, Biendicho A, Blanco R, Boix E, Bonora C, Boxó JR, Brea A, Caballero P, Cabrera P, Cabrero JJ, Calduch L, Calero F, Calvo Garcia JJ, Camacho J, Canales JJ, Caparros J, Carbonell F, Caro M, Castilla MA, Castillo L, Cepero D, Cerdan M, Cimbora A, Civera M, Colchero J, Comas Fuentes A, Corpas C, Corrales JA, Cotobal E, Cruz C, Cruz I, de La Flor MD, de Luis A, del Alamo A, del Rosario V, Diego C, D'Lacoste M, Doganis Peppas C, Dominguez JR, Durá FJ, Durand JL, Ena J, Encinas AR, Erdozain JP, Escribano J, Escriva B, Esteve E, Facila L, Fenoll F, Fernandez E, Fernandez C, Fernandez MJ, Fernandez A, Fernandez J, Fernandez S, Fernandez JM, Fernandez JMF, Ferrer JC, Ferrer P, Ferrer Bascuñana P, Fierro MJ, Flores J, Fuentes F, Fuertes J, Galgo A, Galvez A, Gallego A, Garcia MA, Garcia J, Garcia ML, Garcia P, Garcia J, García F, Garrido NG, Gil MG, Ginés Gascón R, Godoy D, Gomez CM, Gonzalez M, Gonzalez R, Gonzalez R, Gonzalez E, Gonzalez JJ, Gonzalez J, Gonzalez Huambos A, Guerrero J, Guillen R, Guirao L, Gutierrez F, Gutierrez D, Hernandez A, Hernandez A, Hernandis V, Herrero JV, Herreros B, Hevia Roiguez E, Horgue A, Illan F, Inigo P, Ibrahim Jaber A, Jimenez M, Jornet A, Juanola E, Laguna A, Latorre J, Lebron JA, Lecube A, Ledesma C, Ligorria C, Lima J, López JE, Lopez M, López JA, López J, López I, Lozano JV, Mangas MA, Mangas A, Manzano A, Maraver J, Marco MD, Marchán E, Marchante F, Marin F, Marreo JE, Martin M, Martin A, Martin FJ, Martinez A, Martinez G, Martínez L, Martinez Barselo AP, Mas E, Mascareño I, Mascarós E, Massa R, Mazón P, Mediavilla JD, Mena C, Mendez J, Mendez JM, Mezquita Raya P, Millan JM, Millaruelo J, Minguela E, Miret P, Molina M, Molina C, Montagud B, Montalban C, Montiel A, Montoro J, Monze B, Moreno FL, Morillas A, Moro JA, Moya A, Muñiz O, Muñoz M, Navarro VL, Nerin J, Nicolas R, Nogueiras C, Ojeda B, Olmerilla J, Oller G, Ortega A, Ortega M, Ortega M, Ortiz MJ, Otegui Alarduya L, Palet J, Palomo J, Paytubí C, Peiro R, Pelaez C, Peña P, Peñafiel J, Perez A, Perez E, Perez T, Peso M, Pilar JM, Piñeiro C, Plaza JA, Polo N, Portal M, Prieto J, Prieto L, Prieto Novo M, Puñal P, Quesada M, Quindimil JA, Rabade JM, Ramila Beraza LA, Ramirez JM, Ramos JA, Ramos F, Rayo M, Reixa Vizoso S, Reyes A, Rico MA, Ripoll T, Rivera A, Robres M, Rodilla E, Roiguez MA, Roiguez ZJ, Roiguez C, Roiguez P, Roiguez M, Roiguez A, Rojas D, Rosell L, Rossignoli C, Rueda A, Rueda E, Ruix A, Ruiz JA, Ruiz L, Saban J, Saez FJ, Salleras N, Sánchez G, Sanchez G, Sanchez A, Sanfeliu JM, Sangros Gonzalez J, Santos F, Santus E, Sebastian A, Seguro ME, Selles D, Serrano D, Serrano S, Serrano A, Sestorain F, Solbes R, Soriano C, Suárez H, Surroca ML, Tarabini A, Tarraga P, Teixido E, Terron R, Torres A, Tortosa JM, Tortosa F, Valdés C, Valdés P, Valiente JI, Varo A, Vazquez E, Vázquez L, Vela Ruiz de Morales JM, Vericat A, Vicioso P, Vilaplana C, Villazón F, Lidia Viñas LV, Zuagoitia JF, Nörgaard F, Dziamski R, Haglund L, Holm D, Sars M, Jagunic I, Östgård P, Kumlin L, Jacobsson M, Hamad Y, Jäger W, Särhammar L, Olsson A, Boldt-Christmas A, Nyborg K, Kjellström T, Ghazal F, Wikström L, Holby T, Bhiladvala P, Kynde SM, Eizyk EJ, Tengblad A, Christoffersson O, Sjöström A, Kynde C, Katzman P, Tenhunen A, Lennermo K, Lindholm CJ, Löndahl M, Elfstrand A, Grönlund-Brown I, Ziedén B, Minnhagen K, Lindvall P, Fant K, Kaczynski J, Wallmark A, Wallén CE, Wallberg H, Grönquist L, Hansen JA, Björkander I, Timberg I, Rosenqvist U, Fries R, Carlsson JE, Rautio AT, Sjöberg L, Wirdby A, Höök P, Larsson Å, Bergström CL, Jwayed A, Smolowicz A, Lindman AC, Nilsson P, Tarrach G, Carlsson I, Wieloch M, Rindevall P, Strömblad G, Holmberg G, Shahnazarian H, Melchior J, Younan K, Hansson A, Bjurklint D, Borgencrantz B, Sjöström M, Mullaart M, Munoz M, Jakkola V, Romot J, Dash R, Magnusson JO, Ahmed S, Jonsson C, Pipkorn O, Bray E, Wolff A, Black I, Head C, Allan A]] , Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study. DIABETIC MED 2011;28 (11):1343-1351 [PubMed]
Levels JHM, Geurts P, Karlsson H, Maree R, Ljunggren S, Fornander L, Wehenkel L, Lindahl M, Stroes ESG, Kuivenhoven JA, Meijers JCM, High-density lipoprotein proteome dynamics in human endotoxemia. PROTEOME SCI 2011;9 (1):34 [PubMed]
Postema PG, Regeer MV, van der Valk PR, Stroes ESG, Richel DJ, Blue toe syndrome and sunitinib. INT J CLIN ONCOL 2011;16 (5):574-576 [PubMed]
Rensing KL, van Duyvenvoorde HA, Cramer MJ, Teske AJ, Prokop M, Stroes ES, Wit JM, Hermus ARMM, Twickler TB, Case report: low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function. GROWTH HORM IGF RES 2011;21 (4):233-237 [PubMed]
Spijkers LJA, van den Akker RFP, Janssen BJA, Debets JJ, de Mey JGR, Stroes ESG, van den Born BJH, Wijesinghe DS, Chalfant CE, MacAleese L, Eijkel GB, Heeren RMA, Alewijnse AE, Peters SLM, Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide. PLOS ONE 2011;6 (7):e21817 [PubMed]
Stroes ESG, van Wijk DF, Dalcetrapib: turning the tide for CETP inhibition?. LANCET 2011;378 (9802):1529-1530 [PubMed]
van Leuven SI, Mendez-Fernandez YV, Stroes ES, Tak PP, Major AS, Statin therapy in lupus-mediated atherogenesis: two birds with one stone?. ANN RHEUM DIS 2011;70 (2):245-248 [PubMed]
Vergeer AMH. HDL genes & HDL drugs. s.l.: s.n.; 2011. 303p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Kuivenhoven JA, Stroes ESG)
Visser ME. Dyslipidemia, sense, antisense or nonsense?. s.l.: s.n.; 2011. 194p. ISBN 9789461081940 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Stroes ESG; copromotor(s): Dallinga-Thie GM)
Visser ME, Kropman E, Kranendonk ME, Koppen A, Hamers N, Stroes ES, Kalkhoven E, Monajemi H, Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C). DIABETOLOGIA 2011;54 (7):1639-1644 [PubMed]
Visser ME, Lammers NM, Nederveen AJ, van der Graaf M, Heerschap A, Ackermans MT, Sauerwein HP, Stroes ES, Serlie MJ, Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. DIABETOLOGIA 2011;54 (8):2113-2121 [PubMed]
Wang Y, Berbée JFP, Stroes ES, Smit JWA, Havekes LM, Romijn JA, Rensen PCN, CETP expression reverses the reconstituted HDL-induced increase in VLDL. J LIPID RES 2011;52 (8):1533-1541 [PubMed]
Wiersma JJ, Verberne HJ, Meuwese MC, Stroes ESG, van Miert JNI, van Eck-Smit BLF, Tijssen JGP, Piek JJ, Trip MD, Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints. CLIN CHIM ACTA 2011;412 (1-2):86-90 [PubMed]
Akdim F. LDL cholesterol lowering beyond statins. s.l.: s.n.; 2010. 166p. ISBN 9789085599555 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG)
Akdim F, Stroes ESG, Sijbrands EJG, Tribble DL, Trip MD, Jukema JW, Flaim JD, Su J, Yu R, Baker BF, Wedel MK, Kastelein JJP, Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy. J AM COLL CARDIOL 2010;55 (15):1611-1618 [PubMed]
Akdim F, Visser ME, Tribble DL, Baker BF, Stroes ESG, Yu R, Flaim JD, Su J, Stein EA, Kastelein JJP, Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia. AM J CARDIOL 2010;105 (10):1413-1419 [PubMed]
Arsenault BJ, Després JP, Stroes ESG, Wareham NJ, Kastelein JJP, Khaw KT, Boekholdt SM, Lipid assessment, metabolic syndrome and coronary heart disease risk. EUR J CLIN INVEST 2010;40 (12):1081-1093 [PubMed]
Arsenault BJ, Lemieux I, Després JP, Wareham NJ, Stroes ESG, Kastelein JJP, Khaw KT, Boekholdt SM, Comparison between Gradient Gel Electrophoresis and Nuclear Magnetic Resonance Spectroscopy in Estimating Coronary Heart Disease Risk Associated with LDL and HDL Particle Size. CLIN CHEM 2010;56 (5):789-798 [PubMed]
Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ESG, Kastelein JJP, C-reactive protein is a mediator of cardiovascular disease. EUR HEART J 2010;31 (17):2087-U1505 [PubMed]
Bisoendial RJ, Levi M, Tak PP, Stroes ESG, The Prothrombotic State in Rheumatoid Arthritis: An Additive Risk Factor for Adverse Cardiovascular Events. SEMIN THROMB HEMOST 2010;36 (4):452-457 [PubMed]
Bisoendial RJ, Stroes ESG, Kastelein JJP, Tak PP, Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins. NAT REV RHEUMATOL 2010;6 (3):157-164 [PubMed]
Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M, Stroes ESG, Vink H, Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. DIABETOLOGIA 2010;53 (12):2646-2655 [PubMed]
Duivenvoorden R, VanBavel E, de Groot E, Stroes ESG, Disselhorst JA, Hutten BA, Laméris JS, Kastelein JJP, Nederveen AJ, Endothelial shear stress: a critical determinant of arterial remodeling and arterial stiffness in humans--a carotid 3.0-T MRI study. CIRC-CARDIOVASC IMAG 2010;3 (5):578-585 [PubMed]
Franssen R. Abormalities in lipoprotein metabolism: from dysfunctionla HHDL to abnormal processing of triglyceride-rich lipoproteins. s.l.: s.n.; 2010. 272p. ISBN 9789461080929 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG, Dallinga-Thie GM)
Kusters DM, Homsma SJM, Hutten BA, Twickler MTB, Avis HJ, van der Post JA, Stroes ESG, Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy. NETH J MED 2010;68 (1):299-303 [PubMed]
Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton NI, Friis-Møller N, Neuhaus J, Liappis AP, Phillips AN, Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy. JAIDS-J ACQ IMM DEF 2010;54 (3):275-284 [PubMed]
Meuwese MC, Broekhuizen LN, Kuikhoven M, Heeneman S, Lutgens E, Gijbels MJJ, Nieuwdorp M, Peutz CJ, Stroes ESG, Vink H, van den Berg BM, Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein e-deficient mice. PLOS ONE 2010;5 (12):e14262 [PubMed]
Rana JS, Visser ME, Arsenault BJ, Després JP, Stroes ESG, Kastelein JJP, Wareham NJ, Boekholdt SM, Khaw KT, Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. INT J CARDIOL 2010;143 (3):399-404 [PubMed]
Strang AC, Kaasjager HAH, Basart DCG, Stroes ESG, Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey. NETH J MED 2010;68 (4):168-174 [PubMed]
van Leuven SI, van Wijk DF, Volger OL, de Vries JPPM, van der Loos CM, de Kleijn DVP, Horrevoets AJG, Tak PP, van der Wal AC, de Boer OJ, Pasterkamp G, Hayden MR, Kastelein JJP, Stroes ES, Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis. ATHEROSCLEROSIS 2010;211 (1):231-236 [PubMed]
van Wijk DF, Stroes ESG, Dallinga-Thie GM, Novel insights into anti-inflammatory actions of HDL. ATHEROSCLEROSIS 2010;212 (2):388-389 [PubMed]
van Wijk DF, van Leuven SI, Sandhu MS, Tanck MW, Hutten BA, Wareham NJ, Kastelein JJP, Stroes ESG, Khaw KT, Boekholdt SM, Chemokine Ligand 2 Genetic Variants, Serum Monocyte Chemoattractant Protein-1 Levels, and the Risk of Coronary Artery Disease. ARTERIOSCL THROM VAS 2010;30 (7):1460-U466 [PubMed]
Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, Kastelein JJP, Hayden MR, Stroes ESG, Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction. DIABETES CARE 2010;33 (4):869-874 [PubMed]
Visser ME, Akdim F, Tribble DL, Nederveen AJ, Kwoh TJ, Kastelein JJP, Trip MD, Stroes ESG, Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia. J LIPID RES 2010;51 (5):1057-1062 [PubMed]
Visser ME, Kastelein JJ, Stroes ES, Apolipoprotein B synthesis inhibition: results from clinical trials. CURR OPIN LIPIDOL 2010;21 (4):319-323 [PubMed]
Zhang H, Löwenberg EC , Crosby JR, Macleod AR, Zhao C, Gao D, Black C, Revenko AS, Meijers JCM, Stroes ES, Levi M, Monia BP, Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. BLOOD 2010;116 (22):4684-4692 [PubMed]
Arsenault BJ, Lemieux I, Després JP, Gagnon P, Wareham NJ, Stroes ESG, Kastelein JJP, Khaw KT, Boekholdt SM, HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. ATHEROSCLEROSIS 2009;206 (1):276-281 [PubMed]
Arsenault BJ, Rana JS, Stroes ESG, Després JP, Shah PK, Kastelein JJP, Wareham NJ, Boekholdt SM, Khaw KT, Beyond Low-Density Lipoprotein Cholesterol Respective Contributions of Non-High-Density Lipoprotein Cholesterol Levels, Triglycerides, and the Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio to Coronary Heart Disease Risk in Apparently Healthy Men and Women. J AM COLL CARDIOL 2009;55 (1):35-41 [PubMed]
Arsenault BJ, Stroes ESG, Boekholdt MS, Is myeloperoxidase a useful marker to predict the risk of future cardiovascular events?. CURR CARDIOVASC RISK REP 2009;3:137-143
Birjmohun RS, Vergeer M, Stroes ESG, Sandhu MS, Ricketts SL, Tanck MW, Wareham NJ, Jukema JW, Kastelein JJP, Khaw KT, Boekholdt SM, Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study. PLOS ONE 2009;4 (8):e6809 [PubMed]
Bisoendial RJ, Birjmohun RS, Akdim F, van 't Veer C, Spek CA, Hartman D, de Groot ER, Bankaitis-Davis DM, Kastelein JJP, Stroes ESG, C-Reactive Protein Elicits White Blood Cell Activation in Humans. AM J MED 2009;122 (6):582.e1-582.e9 [PubMed]
Bisoendial RJ, Stroes ESG, Tak PP, Where the immune response meets the vessel wall. NETH J MED 2009;67 (8):328-333 [PubMed]
Broekhuizen LN, Mooij HL, Kastelein JJP, Stroes ESG, Vink H, Nieuwdorp M, Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. CURR OPIN LIPIDOL 2009;20 (1):57-62 [PubMed]
Duivenvoorden R, de Groot E, Afzali H, Vanbavel ET, de Boer OJ, Laméris JS, Fayad ZA, Stroes ESG, Kastelein JJP, Nederveen AJ, Comparison of In Vivo Carotid 3.0-T Magnetic Resonance to B-Mode Ultrasound Imaging and Histology in a Porcine Model. JACC-CARDIOVASC IMAG 2009;2 (6):744-750 [PubMed]
Duivenvoorden R, de Groot E, Elsen BM, Laméris JS, van der Geest RJ, Stroes ES, Kastelein JJP, Nederveen AJ, In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. CIRC-CARDIOVASC IMAG 2009;2 (3):235-242 [PubMed]
Duivenvoorden R, de Groot E, Stroes ESG, Kastelein JJP, Surrogate markers in clinical trials-Challenges and opportunities. ATHEROSCLEROSIS 2009;206 (1):8-16 [PubMed]
El-Harchaoui K. The puzzle of high-density lipoprotein in cardiovascular prevention. s.l.: s.n.; 2009. 173p. ISBN 9789085596042 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG, Kuivenhoven JA)
El Harchaoui K, Arsenault BJ, Franssen R, Després JP, Hovingh GK, Stroes ESG, Otvos JD, Wareham NJ, Kastelein JJP, Khaw KT, Boekholdt SM, High-Density Lipoprotein Particle Size and Concentration and Coronary Risk. ANN INTERN MED 2009;150 (2):84-U43 [PubMed]
Franssen R, Sankatsing RR, Hassink E, Hutten B, Ackermans MT, Brinkman K, Oesterholt R, Arenas-Pinto A, Storfer SP, Kastelein JJ, Sauerwein HP, Reiss P, Stroes ES, Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production. ARTERIOSCL THROM VAS 2009;29 (9):1336-1341 [PubMed]
Franssen R, Vergeer M, Stroes ESG, Kastelein JJP, Combination statin-fibrate therapy: safety aspects. DIABETES OBES METAB 2009;11 (2):89-94 [PubMed]
Harchaoui KE, Franssen R, Hovingh GK, Bisoendial RJ, Stellaard F, Kuipers F, Kastelein JJP, Kuivenhoven JA, Stroes ESG, Groen AK, Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia. ATHEROSCLEROSIS 2009;207 (2):614-616 [PubMed]
Harchaoui KEL, Visser ME, Kastelein JJP, Stroes ES, Dallinga-Thie GM, Triglycerides and cardiovascular risk. CURR CARDIOL REV 2009;5 (3):216-222 [PubMed]
Hoefer IE, Stroes ESG, Pasterkamp G, Levi MM, Reekers JA, Verhagen HJM, Meijers JC, Humphries JE, Rotmans JI, Locally Applied Recombinant Plasmin Results in Effective Thrombolysis in a Porcine Model of Arteriovenous Graft Thrombosis. J VASC INTERV RADIOL 2009;20 (7):951-958 [PubMed]
Meuwese MC, Mooij HL, Nieuwdorp M, van Lith B, Marck R, Vink H, Kastelein JJP, Stroes ESG, Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia. J LIPID RES 2009;50 (1):148-153 [PubMed]
Mingozzi F, Meulenberg JJ, Hui DJ, Basner-Tschakarjan E, Hasbrouck NC, Edmonson SA, Hutnick NA, Betts MR, Kastelein JJ, Stroes ES, High KA, AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells. BLOOD 2009;114 (10):2077-2086 [PubMed]
Nieuwdorp M, Meuwese MC, Mooij HL, van Lieshout MHP, Hayden A, Levi M, Meijers JCM, Ince C, Kastelein JJP, Vink H, Stroes ESG, Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. ATHEROSCLEROSIS 2009;202 (1):296-303 [PubMed]
Sankatsing RR, Wit FW, Vogel M, de Groot E, Brinkman K, Rockstroh JK, Kastelein JJP, Stroes ESG, Reiss P, Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors. ATHEROSCLEROSIS 2009;202 (2):589-595 [PubMed]
Stein EA, Stroes ESG, Steiner G, Buckley BM, Capponi AM, Burgess T, Niesor EJ, Kallend D, Kastelein JJP, Safety and tolerability of dalcetrapib. AM J CARDIOL 2009;104 (1):82-91 [PubMed]
Strang AC, Hovingh GK, Stroes ESG, Kastelein JJP, The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches. AM J CARDIOL 2009;104 (10 Suppl):22E-31E [PubMed]
Stroes ESG, Kastelein JJP, Bénardeau A, Kuhlmann O, Blum D, Campos LA, Clerc RG, Niesor EJ, Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats. BRIT J PHARMACOL 2009;158 (7):1763-1770 [PubMed]
van der Steeg WA. Improving cardiovascular disease prevention: from risk assessment to novel therapy. s.l.: s.n.; 2009. 166p. ISBN 9789071382840 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Kuivenhoven JA, Stroes ESG)
van Leuven SI. Inflammation and its echo in atherosclerosis. s.l.: s.n.; 2009. 339p. ISBN 9789490122386 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG)
van Leuven SI, Birjmohun RS, Franssen R, Bisoendial RJ, de Kort H, Levels JHM, Basser RL, Meijers JCM, Kuivenhoven JA, Kastelein JJ, Stroes ES, ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans. J THROMB HAEMOST 2009;7 (2):347-354 [PubMed]
van Werven JR, Hoogduin JM, Nederveen AJ, van Vliet AA, Wajs E, Vandenberk P, Stroes ESG, Stoker J, Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. J MAGN RESON IMAGING 2009;30 (2):444-448 [PubMed]
van Wijk DF, Stroes ESG, Kastelein JJP, Lipid measures and cardiovascular disease prediction. DIS MARKERS 2009;26 (5-6):209-216 [PubMed]
van Wijk DF, Stroes ESG, Monaijemi H, Changing paradigm in HDL metabolism and cellular effects. CLIN LIPIDOL 2009;4 (1):17-27
Vergeer M, Stroes ESG, The pharmacology and off-target effects of some cholesterol ester transfer protein inhibitors. AM J CARDIOL 2009;104 (10 Suppl):32E-38E [PubMed]
Vergouwen MDI, Meijers JCM, Geskus RB, Coert BA , Horn J, Stroes ESG, van der Poll T, Vermeulen M, Roos YBWEM, Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J CEREBR BLOOD F MET 2009;29 (8):1444-1453 [PubMed]
Wijbrandts CA, van Leuven SI, Boom HD, Gerlag DM, Stroes EGS, Kastelein JJP, Tak PP, Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis. ANN RHEUM DIS 2009;68 (8):1316-1321 [PubMed]
Birjmohun RS. HDL on the crossroads of inflammation, coagulation and atherosclerosis. s.l.: s.n.; 2008. 284p. ISBN 97890909023077 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG)
Birjmohun RS, Hovingh GK, Stroes ESG, Hofstra JJ, Dallinga-Thie GM, Meijers JCM, Kastelein JJP, Levi M, Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema. CLIN THER 2008;30 (12):2314-2323 [PubMed]
Burger D, Stroes E, Reiss P, Drug interactions between statins and antiretroviral agents. CURR OPIN HIV AIDS 2008;3 (3):247-251 [PubMed]
El Harchaoui K, Akdim F, Stroes ESG, Trip MD, Kastelein JJP, Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statins. AM J CARDIOVASC DRUG 2008;8 (4):233-242 [PubMed]
Franssen R, Monajemi H, Stroes ESG, Kastelein JJP, Obesity and Dyslipidemia. ENDOCRIN METAB CLIN 2008;37 (3):623-+ [PubMed]
Franssen R, Visser ME, Kuivenhoven JA, Kastelein JJP, Dallinga-Thie GM, Stroes ESG, Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target. FUTURE LIPIDOL 2008;3 (4):385-397
Kastelein JJP, Akdim F, Stroes ESG, Zwinderman AH, Bots ML, Stalenhoef AFH, Visseren FLJ, Sijbrands EJG, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E, Simvastatin with or without ezetimibe in familial hypercholesterolemia. NEW ENGL J MED 2008;358 (14):1431-1443 [PubMed]
Kastelein JJP, Akdim F, Stroes ESG, Zwinderman AH, Bots ML, Stalenhoef AFH, Visseren FLJ, Sijbrands EJG, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E, Simvastatin with or without ezetimibe in familial hypercholesterolemia (vol 358, pg 1431, 2008). NEW ENGL J MED 2008;358 (18):1977
Levi M, Nieuwdorp M, Poll Tvd, Stroes E, Metabolic modulation of inflammation-induced activation of coagulation. SEMIN THROMB HEMOST 2008;34 (1):26-32 [PubMed]
Levi M, Stroes E, Targeting the prevention of plaque rupture as a new strategy for prevention of acute arterial cardiovascular events. CARDIOVASC RES 2008;78 (3):407-408 [PubMed]
Meuwese MC. Targeting the vessel wall in cardiovascular prevention. s.l.: s.n.; 2008. 262p. ISBN 9789085594024 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG, Vink H)
Meuwese MC, Trip MD, van Wissen S, van Miert JNI, Kastelein JJP, Stroes ESG, Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia. ATHEROSCLEROSIS 2008;197 (2):916-921 [PubMed]
Monajemi H. Genes effecting trigliceride metabolism. From steatosis to lipodystrophy. s.l.: s.n.; 2008. 136p. ISBN 9789090234472 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Horrevoets AJG, Pannekoek H; copromotor(s): Stroes ESG)
Nieuwdorp M, Meuwese MC, Mooij HL, Ince C, Broekhuizen LN, Kastelein JJP, Stroes ESG, Vink H, Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J APPL PHYSIOL 2008;104 (3):845-852 [PubMed]
Nieuwdorp M, Vergeer M, Bisoendial RJ, Op 't Roodt J, Levels H, Birjmohun RS, Kuivenhoven JA, Basser R, Rabelink TJ, Kastelein JJP, Stroes ESG, Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus. DIABETOLOGIA 2008;51 (6):1081-1084 [PubMed]
Sankatsing RR. Atherosclerosis in the HIV and Non-HIV setting: detecting and modifying cardiovascular risk. s.l.: s.n.; 2008. 191p. ISBN 9789071382673 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Reiss P; copromotor(s): Stroes ESG)
Stroes ES, Nierman MC, Meulenberg JJ, Franssen R, Twisk J, Henny CP, Maas MM, Zwinderman AH, Ross C, Aronica E, High KA, Levi MM, Hayden MR, Kastelein JJ, Kuivenhoven JA, Intramuscular Administration of AAV1-Lipoprotein Lipase(S447X) Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients. ARTERIOSCL THROM VAS 2008;28 (12):2303-U264 [PubMed]
van der Graaf A, Rodenburg J, Vissers MN, Hutten BA, Wiegman A, Trip MD, Stroes ESG, Wijburg FA, Otvos JD, Kastelein JJP, Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia. J PEDIATR-US 2008;152 (6):873-878 [PubMed]
van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ESG, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJP, High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies. J AM COLL CARDIOL 2008;51 (6):634-642 [PubMed]
van der Zee PM, Meuwese MC, Verberne HJ, de Ruijter M, van Straalen JP, Fischer JC, Sturk A, van Eck-Smit BLF, Stroes ESG, de Winter RJ, Increases in myeloperoxidase levels after exercise in myocardial perfusion scintigraphy are not induced by myocardial ischemia. CLIN CHIM ACTA 2008;395 (1-2):146-150 [PubMed]
van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP, Systemic inflammation as a risk factor for atherothrombosis. RHEUMATOLOGY 2008;47 (1):3-7 [PubMed]
van Leuven SI, Stroes ES, Kastelein JJP, High-density lipoprotein: A fall from grace?. ANN MED 2008;40 (8):584-593 [PubMed]
van Wissen S, Bastiaansen BAJ, Stroobants AK, van den Dool EJ, Idu MM, Levi M, Stroes ESG, Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour--a case report. LUPUS 2008;17 (6):586-590 [PubMed]
Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, Kastelein JJP, Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials. CIRCULATION 2008;118 (24):2515-2522 [PubMed]
Vergeer M, El-Harchaoui K, Stroes ESG, Cholesterol gene polymorphisms and cardiovascular events. NEW ENGL J MED 2008;359 (1):92 [PubMed]
Vergouwen MDI, Vermeulen M, Coert BA , Stroes ESG, Roos YBWEM, Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J CEREBR BLOOD F MET 2008;28 (11):1761-1770 [PubMed]
Visser ME, Jakulj L, Kastelein JJP, Stroes ESG, LDL-C-lowering therapy: current and future therapeutic targets. CURR CARDIOL REP 2008;10 (6):512-520 [PubMed]
Akdim F, El Harchaoui K, Stroes ESG, Kastelein JJP, Antisense apolipoprotein B-100 as novel treatment for hypercholesterolemia: focus on ISIS 301012. FUTURE LIPIDOL 2007;2 (4):387-393
Akdim F, Stroes ESG, Kastelein JJP, Antisense apolipoprotein B therapy: where do we stand?. CURR OPIN LIPIDOL 2007;18 (4):397-400 [PubMed]
Akdim F, van Leuven SI, Kastelein JJP, Stroes ESG, Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?. CURR PHARM DESIGN 2007;13 (10):1003-1012 [PubMed]
Birjmohun RS, Bisoendial RJ, van Leuven SI, Ackermans M, Zwinderman A, Kastelein JJP, Stroes ESG, Sauerwein HP, A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans. METABOLISM 2007;56 (11):1576-1582 [PubMed]
Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ESG, Otvos JD, Wareham NJ, Luben R, Kastelein JJP, Khaw KT, Boekholdt SM, Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. CIRCULATION 2007;116 (18):2029-2035 [PubMed]
Birjmohun RS, Kastelein JJP, Poldermans D, Stroes ESG, Hostalek U, Assmann G, Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients. CURR MED RES OPIN 2007;23 (7):1707-1713 [PubMed]
Birjmohun RS, Stroes ESG, Kastelein JJP, Raising high-density lipoprotein cholesterol for better prevention of cardiovascular disease. FUTURE LIPIDOL 2007;1 (1):47-54
Birjmohun RS, van Leuven SI, Levels JHM, van 't Veer C, Kuivenhoven JA, Meijers JCM, Levi M, Kastelein JJP, van der Poll T, Stroes ESG, High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. ARTERIOSCL THROM VAS 2007;27 (5):1153-1158 [PubMed]
Bisoendial RJ, Kastelein JJP, Peters SLM, Levels JHM, Birjmohun R, Rotmans JI, Hartman D, Meijers JCM, Levi M, Stroes ESG, Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J LIPID RES 2007;48 (4):952-960 [PubMed]
Bisoendial RJ, Kastelein JJP, Stroes ESG, C-reactive protein and atherogenesis: from fatty streak to clinical event. ATHEROSCLEROSIS 2007;195 (2):e10-e18 [PubMed]
Bredie SJH, Stroes ESG, Kastelein JJP, Jukema JW. Van lipidenmetabolisme naar behandeling in: van der Wall EE, Van de Werf F, Zijlstra F, editors. Cardiologie. Houten: Bohn Stafleu van Loghum; 2008. 2de herziene druk, p. 23-32
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire Geneeskunde, 3e herziene druk. Alphen aan de Rijn: Van Zuiden Communications; 2007. 405p. ISBN 978-90-8523-151-6
Deinum J, Stroes ESG, Jukema JW, Peters RJG, editors, Nieuwsbrief Vasculaire Geneeskunde. Alphen aan de Rijn: Van Zuiden Communications; 2007. -p.
El Harchaoui K, van der Steeg WA, Stroes ESG, Kastelein JJP, The role of CETP inhibition in dyslipidemia. CURR ATHEROSCLER REP 2007;9 (2):125-133 [PubMed]
El Harchaoui K, van der Steeg WA, Stroes ESG, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJP, Khaw KT, Boekholdt SM, Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J AM COLL CARDIOL 2007;49 (5):547-553 [PubMed]
Meuwese MC, Stroes ESG, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJP, Khaw KT, Boekholdt SM, Serum Myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals - The EPIC-Norfolk prospective population study. J AM COLL CARDIOL 2007;50 (2):159-165 [PubMed]
Monajemi H, Stroes E, Hegele RA, Fliers E, Inherited lipodystrophies and the metabolic syndrome. CLIN ENDOCRINOL 2007;67 (4):479-484 [PubMed]
Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB, Kalkhoven E, Stroes E, Hegele RA, Leff T, Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. J CLIN ENDOCR METAB 2007;92 (5):1606-1612 [PubMed]
Nierman MC, Rip J, Kuivenhoven JA, Sakai N, Kastelein JJP, de Sain-van der Velden MGM, Stroes ESG, Prinsen BHCMT, Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes. ATHEROSCLEROSIS 2007;194 (2):446-451 [PubMed]
Nieuwdorp M. Metabolic and vascular dysfunction during hyperglycemia induced inflammation. The role of the endothelial glycocalyx on vascular homeostasis in vivo. s.l.: s.n.; 2007. 158p. ISBN 9789090221038 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Hoekstra JBL, Kastelein JJP; copromotor(s): Stroes ESG, Vink H)
Nieuwdorp M, Holleman F, de Groot E, Vink H, Gort J, Kontush A, Chapman MJ, Hutten BA, Brouwer CB, Hoekstra JBL, Kastelein JJP, Stroes ESG, Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. DIABETOLOGIA 2007;50 (6):1288-1293 [PubMed]
Nieuwdorp M, Stroes ESG, Kastelein JJP, Normalization of metabolic syndrome using fenofibrate, metformin or their combination. DIABETES OBES METAB 2007;9 (6):869-878 [PubMed]
Sankatsing RR, Wit FW, Pakker N, Vyankandondera J, Mmiro F, Okong P, Kastelein JJ, Lange JM, Stroes ES, Reiss P, Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy. J INFECT DIS 2007;196 (1):15-22 [PubMed]
Stroes ESG, editor, Abdominale obesitas en cardiometabool risicomanagement. Alphen aan de Rijn: Van Zuiden Communications; 2007. 66p. ISBN 978-90-8523-161-5
Stroes ESG, de Groot E. Flow-gemedieerde arteriële dilatatie en intima-mediadikte van de carotis als surrogate eindpunten voor vaatwandfunctionaliteit, cardiovasculaire ziekte en ziekterisico in: Büller HR, Kastelein JJP, Stroes ESG, editors. Vasculaire Geneeskunde, 3e herziene druk. Alphen aan de Rijn: Van Zuiden Communications; 2007., p. 193-205
van den Berg BM, Nieuwdorp M, Stroes ESG, Vink H. Luminal Glycocalyx: protective barrier between endothelial cells and flowing blood. in: Aird WC, editor. Endothelial Biomedicine. Cambridge: Cambridge University Press; 2007., p. -
van den Bogaard B, van den Born BJH, Stroes ESG. Renineremmers: een nieuwe klasse bloeddrukverlagende medicatie in: Deinum J, Stroes ESG, Jukema JW, Peters RJG, editors. Nieuwsbrief Vasculaire Geneeskunde. Alphen aan de Rijn: Van Zuiden Communications; 2007. 3, p. 17-19
van der Lee M, Sankatsing R, Schippers E, Vogel M, Faetkenheuer E, van der Ven A, Kroon F, Rockstroh J, Wyen C, Baeumer A, de Root E, Koopmans P, Stroes E, Reiss P, Burger D, Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients. ANTIVIR THER 2007;12 (7):1127-1132 [PubMed]
van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ESG, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJP, Khaw KT, Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. ANN INTERN MED 2007;146 (9):640-648 [PubMed]
van Leuven SI, Hezemans R, Levels JH, Snoek S, Stokkers PC, Hovingh GK, Kastelein JJP, Stroes ES, de Groot E, Hommes DW, Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J LIPID RES 2007;48 (12):2640-2646 [PubMed]
van Leuven SI, Stroes ESG, Mannose-binding lectin and agalactosyl IgG and risk of ischemic heart disease in rheumatoid arthritis: comment on the article by Troelsen et al. ARTHRITIS RHEUM-US 2007;56 (6):2097; author reply 2097-2097; author reply 2098 [PubMed]
van Oostrom O, Nieuwdorp M, Westerweel PE, Hoefer IE, Basser R, Stroes ESG, Verhaar MC, Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes. ARTERIOSCL THROM VAS 2007;27 (8):1864-1865 [PubMed]
VanTeeffelen JW, Brands J, Stroes ES, Vink H, Endothelial glycocalyx: sweet shield of blood vessels. TRENDS CARDIOVAS MED 2007;17 (3):101-105 [PubMed]
van 't Veer C, van den Pangaart PS, van Zoelen MAD, de Kruif M, Birjmohun RS, Stroes ES, de Vos AF, van der Poll T, Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J IMMUNOL 2007;179 (10):7110-7120 [PubMed]
Birjmohun RS, van der Steeg WA, Stroes ESG, Kastelein JJP, De rol van het 'high-density'-lipoproteine (HDL)-partikel in de atherogenese en de mogelijkheden om de concentratie daarvan te verhogen. NED TIJDSCHR GENEESKD 2006;150 (41):2245-2250 [PubMed]
Bisoendial RJ. High-density lipoprotein and C-reactive protein, friend and foe in cardiovascular disease. S.l.: s.n.; 2006. 174p. ISBN 9789090209784 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG)
Gouverneur M, Berg B, Nieuwdorp M, Stroes E, Vink H, Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J INTERN MED 2006;259 (4):393-400 [PubMed]
Keller TT, van Leuven SI, Meuwese MC, Wareham NJ, Luben R, Stroes ES, Hack CE, Levi M, Khaw KT, Boekholdt SM, Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. ARTERIOSCL THROM VAS 2006;26 (10):2345-2350 [PubMed]
Klerkx AHEM, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ESG, Kastelein JJP, Kuivenhoven JA, Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. ARTERIOSCL THROM VAS 2006;26 (4):706-715 [PubMed]
Meuwese MC, Franssen R, Stroes ESG, Kastelein JJP, And then there were acyl coenzyme A:cholesterol acyl transferase inhibitors. CURR OPIN LIPIDOL 2006;17 (4):426-430 [PubMed]
Nierman MC. Lipoprotein lipase S477X. From beneficial gene variant to gene therapy. S.l.: s.n.; 2006. 254p. ISBN 9789090213101 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG, Kuivenhoven JA)
Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JAE, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JBL, Kastelein JJP, Stroes ESG, Vink H, Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. DIABETES 2006;55 (4):1127-1132 [PubMed]
Nieuwdorp M, van Haeften TW, Gouverneur MCLG, Mooij HL, van Lieshout MHP, Levi M, Meijers JCM, Holleman F, Hoekstra JBL, Vink H, Kastelein JJP, Stroes ESG, Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. DIABETES 2006;55 (2):480-486 [PubMed]
Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJP, Stroes ESG, Kuivenhoven JA, Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. ARTERIOSCL THROM VAS 2006;26 (6):1236-1245 [PubMed]
Rotmans JI, Heyligers JMM, Stroes ESG, Pasterkamp G, Endothelial progenitor cell-seeded grafts: rash and risky. CAN J CARDIOL 2006;22 (11):929-932 [PubMed]
Rotmans JI, Heyligers JMM, Stroes ESG, Pasterkamp G, Endothelial progenitor cell-seeded grafts: rash and risky. CAN J CARDIOL 2006;22 (13):1113-1116 [PubMed]
van den Berg BM, Nieuwdorp M, Stroes ESG, Vink H, Glycocalyx and endothelial (dys) function: from mice to men. PHARMACOL REP 2006;58 (Suppl):75-80 [PubMed]
van Leuven SI, Kastelein JJP, Allison AC, Hayden MR, Stroes ESG, Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?. CARDIOVASC RES 2006;69 (2):341-347 [PubMed]
van Leuven SI, Kastelein JJP, D'Cruz DP, Hughes GR, Stroes ES, Atherogenesis in rheumatology. LUPUS 2006;15 (3):117-121 [PubMed]
van Leuven SI, Kastelein JJP, Hayden MR, Stroes ES, Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?. LUPUS 2006;15 (11 Suppl. S):11-17
Birjmohun RM, Stroes ESG, Kastelein JJP, Future strategies in the management of dyslipidemia. FUTURE CARDIOL 2005;1 (2):127-130
Birjmohun RS, Hutten BA, Kastelein JJP, Stroes ESG, Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials. J AM COLL CARDIOL 2005;45 (2):185-197 [PubMed]
Bisoendial R, Birjmohun R, Keller T, van Leuven S, Levels H, Levi M, Kastelein J, Stroes E, In vivo effects of C-reactive protein (CRP)-infusion into humans. CIRC RES 2005;97 (12):e115-e116 [PubMed]
Bisoendial RJ, Hovingh GK, El Harchaoui K, Levels JHM, Tsimikas S, Pu K, Zwinderman AE, Kuivenhoven JA, Kastelein JJP, Stroes ESG, Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia. ARTERIOSCL THROM VAS 2005;25 (9):E133-E134 [PubMed]
Bisoendial RJ, Kastelein JJP, Levels JHM, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JCM, Hartman D, Levi M, Stroes ESG, Activation of inflammation and coagulation after infusion of C-reactive protein in humans. CIRC RES 2005;96 (7):714-716 [PubMed]
Bisoendial R, Kastelein J, Stroes E, In response to van den Berg et al: on the direct actions of CRP in humans. CIRC RES 2005;97 (7):e71 [PubMed]
Nierman MC, Prinsen BHCMT, Rip J, Veldman RJ, Kuivenhoven JA, Kastelein JJP, de Sain-van der Velden MGM, Stroes ESG, Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers. ARTERIOSCL THROM VAS 2005;25 (11):2410-2415 [PubMed]
Nierman MC, Rip J, Kuivenhoven JA, van Raalte DH, Hutten BA, Sakai N, Kastelein JJP, Stroes ESG, Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance. METABOLISM 2005;54 (11):1499-1503 [PubMed]
Nierman MC, Rip J, Twisk J, Meulenberg JJM, Kastelein JJP, Stroes ESG, Kuivenhoven JA, Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice. NETH J MED 2005;63 (1):14-19 [PubMed]
Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JBL, Kastelein JJP, Stroes ESG, The endothelial glycocalyx: a potential barrier between health and vascular disease. CURR OPIN LIPIDOL 2005;16 (5):507-511 [PubMed]
Nieuwdorp M, Stroes ESG, Meijers JCM, Büller H, Hypercoagulability in the metabolic syndrome. CURR OPIN PHARMACOL 2005;5 (2):155-159 [PubMed]
Rip J, Nierman MC, Sierts JA, Petersen W, van den Oever K, van Raalte D, Ross CJD, Hayden MR, Bakker AC, Dijkhuizen P, Hermens WT, Twisk J, Stroes E, Kastelein JJP, Kuivenhoven JA, Meulenberg JM, Gene therapy for lipoprotein lipase deficiency: Working toward clinical application. HUM GENE THER 2005;16 (11):1276-1286 [PubMed]
Rotmans JI. Therapeutic strategies to prevent stenosis in arteriovenous grafts for hemodialysis. Studies in a porcine arteriovenous graft model. S.l.: s.n.; 2005. 160p. ISBN 90-9018634-4 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Stroes ESG, Pasterkamp G)
Rotmans JI, Heyligers JMM, Verhagen HJM, Velema E, de Kleijn DPV, Pasterkamp G, Nagtegaal MM, Stroes ESG, de Groot PG, Letter regarding article by Rotmans et al, "In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts" - Response. CIRCULATION 2005;112 (24):E359-E360
Rotmans JI, Heyligers JMM, Verhagen HJM, Velema E, Nagtegaal MM, de kleijn DPV, de Groot FG, Stroes ESG, Pasterkamp G, In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. CIRCULATION 2005;112 (1):12-18 [PubMed]
Rotmans JI, Pasterkamp G, Verhagen HJM, Pattynama PMT, Blankestijn PJ, Stroes ESG, Hemodialysis access graft failure: Time to revisit an unmet clinical need?. J NEPHROL 2005;18 (1):9-20 [PubMed]
Rotmans JI, Pattynama PMT, Verhagen HJM, Hino I, Velema E, Pasterkamp G, Stroes ESG, Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts - A 4-week follow-up study. CIRCULATION 2005;111 (12):1537-1542 [PubMed]
Rotmans JI, Stroes ESG, Pasterkamp G, Letter regarding article by Luo et al, "Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs". CIRCULATION 2005;112 (12):E153 [PubMed]
Sankatsing RR, de Groot E, Jukema JW, de Feyter PJ, Pennell DJ, Schoenhagen P, Nissen SE, Stroes ESG, Kastelein JJP, Surrogate markers for atherosclerotic disease. CURR OPIN LIPIDOL 2005;16 (4):434-441 [PubMed]
Sankatsing RR, Fouchier SW, de Haan S, Hutten BA, de Groot E, Kastelein JJP, Stroes ESG, Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. ARTERIOSCL THROM VAS 2005;25 (9):1979-1984 [PubMed]
Stroes E, Statins and LDL-cholesterol lowering: an overview. CURR MED RES OPIN 2005;21 (Suppl. 6):S9-S16 [PubMed]
Stroes ESG, editor, Hart- en vaatziekten, dl. 1. Cardiovasculaire preventie in perspectief. Leusden: Mark Two Communications bv; 2005. -p.
van Leuven SI, Kastelein JJP, Hayden MR, d'Cruz D, Hughes GR, Stroes ES, Cardiovascular disease in systemic lupus erythematosus: has the time for action come?. CURR OPIN LIPIDOL 2005;16 (5):501-506 [PubMed]
Birjmohun RS, Hutten BA, Kastelein JJP, Stroes ESG, Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice. NETH J MED 2004;62 (7):229-234 [PubMed]
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde; 2e herz. dr. Alphen/ad Rijn: Van Zuiden; 2004. -p.
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde; 2e herz dr. Alphen a/d Rijn: van Zuiden; 2004. -p.
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde; 2e herz. dr. Alphen a/d Rijn: Van Zuiden; 2004. -p.
de Grooth GJ, Klerkx AHEM, Stroes ESG, Stalenhoef AFH, Kastelein JJP, Kuivenhoven JA, A review of CETP and its relation to atherosclerosis. J LIPID RES 2004;45 (11):1967-1974 [PubMed]
Fruchart JC, Nierman MC, Stroes ESG, Kastelein JJP, Duriez P, New risk factors for atherosclerosis and patient risk assessment. CIRCULATION 2004;109 (23 Suppl 1):III15-III19 [PubMed]
Hovingh GK, Brownlie A, Bisoendial RJ, Dube MP, Levels JHM, Petersen W, Dullaart RPF, Stroes ESG, Zwinderman AH, de Groot E, Hayden MR, Kuivenhoven JA, Kastelein JJP, A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J AM COLL CARDIOL 2004;44 (7):1429-1435 [PubMed]
Kastelein JJP, Stroes ESG, de Groot E, Subclinical atherosclerosis as a target of therapy: Potential role of statins. AM J CARDIOL 2004;93 (6):737-740 [PubMed]
Rotmans JI, Velema E, Verhagen HJM, Blankensteijn JD, de kleijn DPV, Stroes ESG, Pasterkamp G, Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. J VASC SURG 2004;39 (2):432-439 [PubMed]
Rotmans JI, Verhagen HJM, Velema E, de kleijn DPV, van den Heuvel M, Kastelein JJP, Pasterkamp G, Stroes ESG, Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts. KIDNEY INT 2004;65 (5):1897-1905 [PubMed]
Stroes ESG, de Groot E. Flow-gemedieerde arteriële dilatatie en carotis-intima-mediadikte als surrogate eindpunten voor vaatwandfunctionaliteit, cardiovasculiare ziekte en ziekterisico in: Büller HR, Kastelein JJP, Stroes ESG, editors. Vasculaire geneeskunde; 2e herz dr. Alphen a/d Rijn: van Zuiden; 2004., p. 189-199
van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, Wood R, Bloch M, Katlama C, Kastelein JJP, Schechter M, Murphy RL, Horban A, Hall DB, Lange JMA, Reiss P, Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLOS MED 2004;1 (1):e19-74 [PubMed]
Bisoendial RJ, Hovingh GK, Levels JHM, Lerch PG, Andresen I, Hayden MR, Kastelein JJP, Stroes ESG, Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. CIRCULATION 2003;107 (23):2944-2948 [PubMed]
de Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJP, Stroes ESG, Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J INHERIT METAB DIS 2003;26 (4):343-351 [PubMed]
Lilien MR, Stroes ES, Op't Roodt J, de Jongh S, Schröder CH, Koomans HA, Vascular function in children after renal transplantation. AM J KIDNEY DIS 2003;41 (3):684-691 [PubMed]
Rotmans JI, Velema E, Verhagen HJM, Blankensteijn JD, Kastelein JJP, de Kleijn DPV, Yo M, Pasterkamp G, Stroes ESG, Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine, bilateral, carotid arteriovenous graft model. J SURG RES 2003;113 (1):161-171 [PubMed]
Bisoendial RJ, Hovingh GK, de Groot E, Kastelein JJP, Lansberg PJ, Stroes ESG, Measurement of subclinical atherosclerosis: beyond risk factor assessment. CURR OPIN LIPIDOL 2002;13 (6):595-603 [PubMed]
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde. S.l.: Van Zuiden Communications; 2002. -p.
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde. Alphen a/d Rijn: Van Zuiden communications; 2002. 356p. ISBN 90 76906 34 3
de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJP, Stroes ESG, Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. ATHEROSCLEROSIS 2002;163 (1):193-197 [PubMed]
de Jongh S, Lilien MR, Op't Roodt J, Stroes ESG, Bakker HD, Kastelein JJP, Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J AM COLL CARDIOL 2002;40 (12):2117-2121 [PubMed]
Diercks GFH, Stroes ESG, van Boven AJ, van Roon AM, Hillege HL, de Jong PE, Smit AJ, Gans ROB, Crijns HJGM, Rabelink TJ, van Gilst WH, Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects. DIABETES CARE 2002;25 (5):936-937 [PubMed]
Diercks GFH, Stroes ESG, van Boven AJ, van Roon AM, Hillege HL, de Jong PE, Smit AJ, Gans ROB, Crijns HJGM, Rabelink TJ, van Gilst WH, Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. ATHEROSCLEROSIS 2002;163 (1):121-126 [PubMed]
Hijmering ML, Stroes ESG, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ, Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J AM COLL CARDIOL 2002;39 (4):683-688 [PubMed]
Monnink SHJ, van Haelst PL, van Boven AJ, Stroes ESG, Tio RA, Plokker TWM, Smit AJ, Veeger NJGM, Crijns HJGM, van Gilst WH, Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests. J INVEST MED 2002;50 (1):19-24 [PubMed]
Rooyakkers TM, Stroes ESG, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJM, Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. EUR J CLIN INVEST 2002;32 (Suppl. 1):9-16 [PubMed]
Stroes ESG. Flow-gemedieerde vaatverwijding in de arteria brachialis in: Büller HR, Kastelein JJP, Stroes ESG, editors. Vasculaire geneeskunde. S.l.: Van Zuiden Communications; 2002., p. 169-208
van Etten RW, de Koning EJP, Honing ML, Stroes ES, Gaillard CA, Rabelink TJ, Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. ARTERIOSCL THROM VAS 2002;22 (5):799-804 [PubMed]
Wilmink HW , Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, Rabelink TJ, Stroes ES, Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles. CARDIOVASC RES 2001;50 (3):577-582 [PubMed]
Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Lüscher T, Rabelink T, Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J CLIN INVEST 1997;99 (1):41-46 [PubMed]
Key publications

van der Valk FM, Bekkering S, Kroon J, Yeang C, van den Bossche J, van Buul JD, Ravandi A, Nederveen AJ, Verberne HJ, Scipione C, Nieuwdorp M, Joosten LAB, Netea MG, Koschinsky ML, Witztum JL, Tsimikas S, Riksen NP, Stroes ESG, Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. CIRCULATION 2016;134 (8):611-624 [PubMed]
Viney NJ, van Capelleveen JC, Geary RS, Xia S, Tami JA, Yu RZ, Marcovina SM, Hughes SG, Graham MJ, Crooke RM, Crooke ST, Witztum JL, Stroes ES, Tsimikas S, Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. LANCET 2016;388 (10057):2239-2253 [PubMed]
Jakulj L, van Dijk TH, de Boer JF, Kootte RS, Schonewille M, Paalvast Y, Boer T, Bloks VW, Boverhof R, Nieuwdorp M, Beuers UHW, Stroes ESG, Groen AK, Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion. CELL METAB 2016;24 (6):783-794 [PubMed]
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJP [Contributors: Caccavo A, Codutti O, Gelersztein E, Vico M, Zaidman C, Majul C, Balthazar Y, Capiau L, Vrolix M, Vermeersch P, Gotchev D, Todorov G, Tumbev H, Tzekova M, Gronkova N, Dimov B, Nikolaeva A, Devedzhiev T, Mincheva V, D'Ignazio G, Dzongowski P, Elliott T, Hart R, Hoag G, Martinho V, O'Mahony M, Tellier G, Bergeron J, Pandey S, Heaton K, Constance C, Phaneuf DC, Shu D, Narvaez NC, Cañon CO, Cardenas SP, Loayza MS, de Salazar DM, Lopez RB, Gomez JI, Mendoza JA, Cure CC, Ceska R, Zidkova E, Jansky P, Egstrup K, Klausen IBC, Lomholdt J, Gislason G, Torp-Pedersen C, Poulsen S, Kuusela M, Kekki S, Nieminen S, Tuomilehto J, Boye A, Bruckert E, Cadinot D, Farnier M, Lejay D, Luc G, Revol T, Schaupp T, Krempf M, Bonnet J, Paillard F, Moulin P, Junggeburth J, Isermann B, Zühlke M, Züchner D, Theis E, Stößel J, König HJ, Rinke A, Piechatzek R, Contzen C, Lappo M, Himpel-Boenninghoff AA, Meissner G, Maus O, Degtyareva E, Schulze ED, Horacek T, Marten I, Becher P, Matoltsy A, Nyirati G, Paragh G, Zilahi Z, Nagy K, Kanakaridisz N, Beke E, Biro J, Schnabel R, Elias M, Gavish D, Francis A, Nseir W, Zimlichman R, Averna M, Pozzi C, Lembo G, Bucci M, Mezzetti A, Rubba P, de Pellegrin AM, Salvioni A, de Cesare N, Briones IR, Campos PF, Rosas EL, Espinosa EV, Salazar MA, Ruiz AB, Furusho LC, Olvera I, Stroes E, van den Berg R, Basart D, Köse V, Kentgens S, Peeters M, Hoogendijk J, Voors-Pette C, Agous I, van Kempen W, Lingan GR, Kooy A, Troquay R, Herrman J, Hoivik H, Langslet G, Norheim P, Risberg K, Høivik HO, Elle S, Derezinski T, Miekus P, Ogorek M, Szymkowiak K, Cesar M, Gawron A, Dabrowska M, Blach E, Konieczny M, Sidor M, Matias F, da Silva PM, Carvalho D, Mendonca I, Andor M, Andrei L, Podoleanu C, Pop C, Chizhov P, Chumakova G, Goloschekin B, Libov I, Paltsman Z, Strutinskiy A, Koziolova N, Breedt J, Ebrahim I, Ellis G, Fulat M, van Rensburg DJ, Raal F, van Dyk C, Vally T, van der Walt E, Kotzé H, Landman C, Tayob M, Caixas A, García LR, Fernandez-Cruz A, Gil-Extremera B, Grijalvo OM, Plana N, Fuentes F, Valdivielso P, Fraile B, Borgencrantz B, Larnefeldt H, Tengmark BO, Eriksson M, Olsson-Önerud Å, Amalyan W, Dyadyk O, Koval O, Kushnir M, Svintsitskiy A, Kovalyov O, Bondarchuk O, Tashchuk V, Barna O, Prokhorov O, Karpenko O, Stanciu D, Pawa R, Balaji H, Doig F, Harvey P, Ranganath L, Massalski W, Hassanin H, Timmis H, Pavel-Knox I, Abdulhakim E, Oyesile B, Horvathova V, Donnachie H, Kondagunta V, Shaw H, Thomas H, Kadr H, Gunstone A, Lip G, Ellery A, Kerrane J, Sarker A, Wong Yk, Soran H, Maw K, Andersen J, Blair-Britt L, Huffman C, Kivitz A, Marple R, Patron A, Schear M, Allegar N, Awasty V, Casanova R, Chaykin L, Cohen L, Collins H, Collins G, Elkin G, Reyes H, Feld L, Fuller G, Glover R, Greenwald J, Herrod J, Kaye W, Kimmel M, Kolettis E, Lakin G, Lorch D, Palatnik M, Patel R, Reichman A, Rohlf J, Shockey G, Shore K, Radin D, Alvarado O, Bellingar B, Egelhof R, McKnight T, Plevin S, Pritchard J, Reddy R, Velazquez F, Bolster E, Broker R, Butuk D, Cheung D, Cohen K, Golden G, Murray A, Naccarato T, Uusinarkaus K, Pudi K, Graff A, Blumberg V, Dunn F, Toth P, Anspach R, Chuang R, Meli J, Nevins B, Wayne J, Schmidt L, Levinsky D, Rubino J, Shealy N, Torres D, West J, Jain R, Vardi G, Singh N, Thew S, Lo E, Heitner J, Gerber J, Malik A, Weinstein D, Prashad R, Koren M, Ghitis A, David W, Reis G, Kinzfogl G, Haught H, Kantaros L, O'dea D, Weiss D, Kassas S, Hunter J, Mollod M, Khan N, Henderson D, Gatien L, Schramm R, Madder R, El Shahawy M, Voyce S, Nadar V, Stich M, Kumar M, Black R, Treasure C, Lebeis M, McCullough P, Lepor N, Moriarty P, Waxler A, Talreja D, Gen M, Dohad S, East C, Conrad G, Asbill B, Roberts J, Robinson J, Zarich S, Davis B, Krolick M, Sherman H, Thompson P]] , Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events. NEW ENGL J MED 2015;372 (16):1489-1499 [PubMed]
Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, Otten MJ, Zaidi N, Lobatto ME, van Rijs SM, Priem B, Kuan EL, Martel C, Hewing B, Sager H, Nahrendorf M, Randolph GJ, Stroes ESG, Fuster V, Fisher EA, Fayad ZA, Mulder WJM, A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. NAT COMMUN 2014;5:3065 [PubMed]


All Publications

Research programmes

Novel anti-atherogenic strategies targeting the vessel wall

During the past decade the applicant has focused at the pathophysiology of atherogenesis, focusing at the role of the vessel wall as a potential new therapeutic target. In the quest to optimize therapeutic options for patients at increased cardiovascular diseases, several lines of research are being pursued:

- Imaging: Early treatment of atherosclerotic disease requires careful phenotyping of patients and early detection of atherosclerotic disease. In collaboration with Nederveen (Dept radiology), the applicant has focused at 3T-magnetic resonance of predominantly the carotid artery as a surrogate marker for atherogenesis/cardiovascular disease.
In collaboration with Prof Fayad (Mount Sinai, New York) the applicant has also focused at the vessel wall inflammation. Using translational protocols, the impact of inflammation throughout the course of atherogenesis is evaluated, using multi-modality imaging as well as innovative anti-inflammatory compounds. 

Nanotechnology targeting the vessel wall: In collaboration with Willem Mulder (Mount Sinai, NY) and prof Storm (Utrecht) several nanoparticles are being evaluated preclinically as well as clinically to target inflammation within the atherosclerotic plaque. This research is part of a European framework (FP7), in which the Vascular medicine department is responsible for the clinical trials for novel nanotherapeutics. Theme: Cardiovascular Diseases

Reverse cholesterol transport: HDL-increasing strategies: LDL lowering reduces CV risk by 30%, most likely limited by the fact that statins stabilize the disease without the potential to induce reversibility of the lesions. HDL has been proposed to have the capacity to reverse lesions. The applicant is involved in the development and early clinical testing of a wide variety of HDL increasing compounds (CETP inhibitors, nicotinic acid derivatives, apoAI mimetics) to be used as therapeutic agents in patients at increased CV risk

Faculty
Prof. dr. E.S.G. Stroes MD PhD
Dr. B.J.H. van den Born MD PhD
Dr. G.K. Hovingh MD PhD (visiting professor at Imperial College London UK)
Prof. J.J.P. Kastelein MD PhD
Dr. ir. A.J. Nederveen
Prof. dr. M. Nieuwdorp MD PhD

Postdocs
Dr. M. Bahjat
Dr. J. Kroon PhD

PhD Students
L. Ali
R. van der Bel
Drs. M.A.W. Van den Boogert MD
Drs. K.E.C. Bouter
C.S. Bruikman
Drs. J.C. van Capelleveen
T.W. Emans
M.L. Hartgers
R.M. Hoogeveen MD
Drs. R.S. Kootte
I. Nicorescu
L.F. Reeskamp MD
A.M.R. Sabry
J.G. Schnitzler
Drs. L.P. Smits
L.C.A. Stiekema
Drs. R.P. Surendran
N.K.L.M. Timmers
R. Verbeek
S.L. Verweij
Q. Zhang MSc
K.H. Zheng MD

Prof. dr. M. Nieuwdorp MD PhD (Gutmicrobiota as novel diagnostic and therapeutic targets in cardiometabolism)

Other research related activities
  • Membership of medical or scientific committee, Other, Chair Dutch Atherosclerosis Society
  • Membership of medical or scientific committee, Vascular Biology Working group, vascular research society
  • Membership of medical or scientific committee, NWO: Netherlands Organisation, VIDI selection committee member
Current research funding
  • AMC
  • AMC (Vrijgesteld)
  • Amgen BV
  • Amsterdam Cardiovascular Sciences
  • Athera Biotechnologies AB
  • Daiichi Sankyo Pharma Development
  • Elsevier B.V.
  • Europese Unie
  • ICTA PM
  • Medical Research BV
  • Merck Sharp & Dohme BV
  • Merck Sharp & Dohme Corp.
  • Nederlandse Hartstichting
  • Novartis Pharma BV
  • PAREXEL Nederland B.V.
  • Portola Pharmaceuticals Inc.
  • Quintiles
  • Radboud Universiteit Nijmegen
  • Regeneron Pharmaceuticals, Inc.
  • Resverlogix Corp.
  • Stichting AMC Foundation (Vrijgesteld)
  • Stichting Metakids
  • Stichting Vascular Research Support
  • Thrombosis Research Institute
  • UBC Late Stage (UK) Limited
  • UniQure Biopharma BV
  • Vascular Research Network BV
  • ZonMw